Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Thomas Gauler

Funktionen

  • Mitglied/er, Innere Klinik (Tumorforschung)

Aktuelle Veranstaltungen

Keine aktuellen Veranstaltungen.

Vergangene Veranstaltungen (max. 10)

Keine vergangenen Veranstaltungen.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Aymane, Khouya; Alina, Santiago; Toke, Ringbaek; Nika, Guberina; Maja, Guberina; Thomas, Gauler; Wolfgang, Lübcke; Waldemar, Zylka; Christoph, Pöttgen; Martin, Stuschke; Khouya, Aymane; Santiago, Alina; Ringbaek, Toke; Guberina, Nika; Guberina, Maja; Gauler, Thomas; Lübcke, Wolfgang; Zylka, Waldemar; Pöttgen, Christoph; Stuschke, Martin
    Are treatment plans optimized on the basis of acuros XB dose calculation robust against anatomic changes during online adaptive radiotherapy for lung cancer regarding dose homogeneity?
    In: Radiation Oncology, Jg. 20, 2025, Nr. 1, 75
    DOI (Open Access)
  • Metzenmacher, Martin; Zaun, Gregor; Özkan, Filiz; Winantea, Jane; Doerr, Fabian; Gauler, Thomas; Guberina, Maja; Eberhardt, Wilfried
    Multimodale Therapiekonzepte beim lokal fortgeschrittenen NSCLC
    In: TumorDiagnostik & Therapie, Jg. 46, 2025, Nr. 2, S. 113 – 116
    DOI
  • Wark, Antje; Kim, Ji-Young; Mavriopoulou, Elena; la Fougère, Christian; Wiegel, Thomas; Scholz, Christian W.; Baues, Christian; Li, Minglun; Gauler, Thomas; Combs, Stephanie E.; Herfarth, Klaus
    PET/CT-based target volume definition in involved-site radiotherapy for treatment of early-stage nodal follicular lymphoma
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 201, 2025, Nr. 11, S. 1137 – 1142
    DOI (Open Access)
  • Guberina, Maja; Metzenmacher, Martin; Pöttgen, Christoph; Wiesweg, Marcel; Guberina, Nika; Merkel-Jens, Anja; Lütke-Brintrup, Diana; Bölükbas, Servet; Eberhardt, Wilfried; Stamatis, Georgios; Doerr, Fabian; Plönes, Till; Hoffmann, Christian; Zaun, Gregor; Höing, Benedikt; Kürten, Cornelius; Mladenov, Emil; Iliakis, George; Kersting, David; Fendler, Wolfgang; Gauler, Thomas; Opitz, Marcel; Milosevic, Aleksandar; Forsting, Michael; Nensa, Felix; Umutlu, Lale; Funke, Faustina; Hautzel, Hubertus; Herrmann, Ken; Taube, Christian; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin
    Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer
    In: Thoracic Cancer, Jg. 16, 2025, Nr. 22, e70183
    DOI (Open Access)
  • Kürten, Cornelius H. L.; Sivakumar, Vinithagowry; Waßenberg, Sebastian; Schleupner, Marie Carolin; Funk, Valentin; Lazzarini, Elena; Aksu, Sara; Guberina, Maja; Gauler, Thomas; Stuschke, Martin; Mattheis, Stefan; Lang, Stephan; Hussain, Timon
    Pre-treatment anemia in head and neck cancer : risk factors, subtypes, and survival outcomes
    In: Frontiers in Oncology, Jg. 15, 2025, 1577901
    DOI (Open Access)
  • Schulte, Christina; Gauler, Thomas; Pöttgen, Christoph; Friedel, Godehard; Kopp, Hans-Georg; Fischer, Berthold; Schmidberger, Heinz; Kimmich, Martin; Budach, Wilfried; Cordes, Sebastian; Wienker, Johannes; Metzenmacher, Martin; de Los Rios, Rodrigo Hepp; Spengler, Werner; De Ruysscher, Dirk; Belka, Claus; Welter, Stefan; Luetke-Brintrup, Diana; Guberina, Maja; Oezkan, Filiz; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
    In: International Journal of Cancer, Jg. 156, 2025, Nr. 1, S. 154 – 163
    DOI (Open Access)
  • Herz, Andreas; Guberina, Maja; Pöttgen, Christoph; Gauler, Thomas; Ton, That Truong Mike; Fischedick, Gerrit; Kiwitt, Lars Oliver; Lübcke, Wolfgang; Hoffmann, Christian; Schuler, Martin; Metzenmacher, Martin; Schaarschmidt, Benedikt; Bos, Denise; Opitz, Marcel; Hautzel, Hubertus; Darwiche, Kaid; Bölükbas, Servet; Grapatsas, Konstantinos; Jendrossek, Verena; Gockeln, Lena; Wirsdörfer, Florian; Hetzel, Mario; Mladenov, Emil; Stuschke, Martin; Guberina, Nika
    The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis
    In: Translational Lung Cancer Research, Jg. 14, 2025, Nr. 6, S. 2074 – 2088
    DOI (Open Access)
  • Hoffmann, Christian; Hautzel, Hubertus; Wiesweg, Marcel; Kersting, David; Guberina, Nika; Pöttgen, Christoph; Metzenmacher, Martin; Schuler, Martin; Gauler, Thomas; Höing, Benedikt; Kürten, Cornelius; Doerr, Fabian; Bölükbas, Servet; Baldes, Natalie; Opitz, Marcel; Milosevic, Aleksandar; Nensa, Felix; Umutlu, Lale; Funke, Faustina; Fendler, Wolfgang; Herrmann, Ken; Stuschke, Martin; Guberina, Maja
    [18F]FDG-PET/CT-based evaluation of tumor response kinetics during induction chemotherapy and concurrent radiochemotherapy in stage II - III small-cell lung cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging, 2025, in press
    DOI (Open Access)
  • Doehn, Christian; Bergmann, L.; Decker, J.; Gauler, Thomas; Grünwald, Viktor; Weikert, St.; Krege, Susanne
    Aktualisierte S3-Leitlinie Nierenzellkarzinom
    In: Die Urologie, Jg. 63, 2024, Nr. 5, S. 439 – 447
    DOI
  • Guberina, Maja; Pöttgen, Christoph; Guberina, Nika; Hoffmann, Christian; Wiesweg, Marcel; Richlitzki, Cedric; Metzenmacher, Martin; Aigner, Clemens; Bölükbas, Servet; Gauler, Thomas; Eberhardt, Wilfried; Forsting, Michael; Herrmann, Ken; Theegarten, Dirk; Darwiche, Kaid; Jendrossek, Verena; Stuschke, Martin; Schuler, Martin
    Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III Disease
    In: Cancers, Jg. 16, 2024, Nr. 6, 1174
    DOI (Open Access)
  • Guberina, Maja; Guberina, Nika; Hoffmann, C.; Gogishvili, A.; Freisleben, F.; Herz, A.; Hlouschek, J.; Gauler, Thomas; Lang, Stephan; Stähr, K.; Höing, B.; Pöttgen, Christoph; Indenkämpen, Frank; Santiago, A.; Khouya, A.; Mattheis, Stefan; Stuschke, Martin
    Prospects for online adaptive radiation therapy (ART) for head and neck cancer
    In: Radiation Oncology, Jg. 19, 2024, Nr. 1, 4
    DOI (Open Access)
  • Khouya, Aymane; Pöttgen, Christoph; Hoffmann, Christian; Ringbaek, Toke Printz; Lübcke, Wolfgang; Indenkämpen, Frank; Guberina, Maja; Guberina, Nika; Gauler, Thomas; Stuschke, Martin; Santiago Garcia, Alina
    Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer
    In: Cancers, Jg. 15, 2023, Nr. 23, 5629
    DOI (Open Access)
  • Guberina, Maja; Santiago Garcia, Alina; Khouya, Aymane; Pöttgen, Christoph; Holubyev, Kostyantyn; Ringbaek, Toke Printz; Lachmuth, Manfred; Alberti, Yasemin; Hoffmann, Christian; Hlouschek, Julian; Gauler, Thomas; Lübcke, Wolfgang; Indenkämpen, Frank; Stuschke, Martin; Guberina, Nika
    Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin
    In: JAMA Network Open, Jg. 6, 2023, Nr. 3, S. e234066
    DOI (Open Access)
  • Pöttgen, Christoph; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ringbaek, Toke; Santiago Garcia, Alina; Krafft, Ulrich; Hadaschik, Boris; Khouya, Aymane; Stuschke, Martin
    Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer : Answers from a Prospective Registry
    In: Cancers, Jg. 15, 2023, Nr. 20, 4933
    DOI (Open Access)
  • Kansy, Benjamin A.; Wehrs, Tim P.; Bruderek, Kirsten; Si, Yu; Ludwig, Sonja; Droege, Freya; Hasskamp, Pia; Henkel, Uta; Dominas, Nina; Hoffmann, Thomas K.; Horn, Peter A.; Schuler, Martin; Gauler, Thomas C.; Lindemann, Monika; Lang, Stephan; Bankfalvi, Agnes; Brandau, Sven
    HPV-associated head and neck cancer is characterized by distinct profiles of CD8⁺ T cells and myeloid-derived suppressor cells
    In: Cancer Immunology, Immunotherapy, Jg. 72, 2023, S. 4367 – 4383
    DOI (Open Access)
  • Hoffmann, Christian; Ringbaek, Toke; Eckstein, Anja; Deya, Wolfgang; Santiago, Alina; Heintz, Martin; Lübcke, Wolfgang; Indenkämpen, Frank; Sauerwein, Wolfgang; Flühs, Andrea; Le Guin, Claudia; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia; Deuschl, Cornelius; Moliavi, Sourour; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Johansson, Patricia; Bechrakis, Nikolaos; Stuschke, Martin; Guberina, Maja
    Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy : Results from a Longitudinal Study
    In: Cancers, Jg. 15, 2023, Nr. 22, 5433
    DOI (Open Access)
  • Hoffmann, Christian; Mohr, Christopher; Johansson, Patricia; Eckstein, Anja; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia Luise; Deuschl, Cornelius; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Bechrakis, Nikolaos; Stuschke, Martin; Guberina, Maja
    MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kinetics
    In: Scientific Reports, Jg. 13, 2023, Nr. 1, 4792
    DOI, Online Volltext (Open Access)
  • Wiegand, Susanne; Wichmann, Gunnar; Vogt, Jeannette; Vogel, Kathrin; Franke, Annegret; Kuhnt, Thomas; Lordick, Florian; Scheuble, Anne-Marie; Hambsch, Peter; Brossart, Peter; Bauernfeind, Franz Georg; Kaftan, Holger; Maschmeyer, Georg; Paland, Matthias; Münter, Marc; Lewitzki, Victor; Rotter, Nicole; Stromberger, Carmen; Beck, Marcus; Dommerich, Steffen; Gauler, Thomas; Hapke, Gunnar; Guntinas-Lichius, Orlando; Schröder, Ursula; Görner, Martin; Hautmann, Matthias G.; Steger, Felix; Tamaskovics, Bálint; Schmiedeknecht, Anett; Dietz, Andreas
    Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma : the study protocol of the Adrisk trial
    In: Frontiers in Oncology, Jg. 13, 2023, 1128176
    DOI (Open Access)
  • Guberina, Maja; Santiago, Alina; Pöttgen, Christoph; Indenkämpen, Frank; Lübcke, Wolfgang; Qamhiyeh, Sima; Gauler, Thomas; Hoffmann, C.; Guberina, Nika; Stuschke, Martin
    Respiration-controlled radiotherapy in lung cancer : Systematic evaluation of the optimal application practice
    In: Clinical and Translational Radiation Oncology, Jg. 40, 2023, 100628
    DOI, Online Volltext (Open Access)
  • Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried
    Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors
    In: Immunotherapy, Jg. 14, 2022, Nr. 12, S. 927 – 944
    DOI (Open Access)
  • Hoffmann, Christian; Rating, Philipp; Bechrakis, Nikolaos; Eckstein, Anja; Sokolenko, Ekaterina; Jabbarli, Leyla; Westekemper, Henrike; Mohr, Christopher; Schmeling, Claus; Hüttmann, Andreas; von Tresckow, Julia; Göricke, Sophia Luise; Deuschl, Cornelius; Johansson, Patricia; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Moliavi, Sourour; Stuschke, Martin; Guberina, Maja
    Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal study
    In: Hematological Oncology, Jg. 40, 2022, Nr. 5, S. 922 – 929
    DOI (Open Access)
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Darwiche, Kaid; Aigner, Clemens; Eberhardt, Wilfried; Stuschke, Martin
    Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
    In: Radiation Oncology, Jg. 17, 2022, Nr. 1, 126
    DOI, Online Volltext (Open Access)
  • Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
    In: Scientific Reports, Jg. 12, 2022, Nr. 1, 17511
    DOI, Online Volltext (Open Access)
  • Goerling, Ute; Gauler, Thomas; Dietz, Andreas; Grünwald, Viktor; Knipping, Stephan; Guntinas-Lichius, Orlando; Frickhofen, Norbert; Lindeman, Hans-Walter; Fietkau, Rainer; Haxel, Boris; Große-Thie, Christina; Maschmeyer, Georg; Zipfel, Matthias; Martus, Peter; Knoedler, Maren; Keilholz, Ulrich; Klinghammer, Konrad; Lindemann, Hans-Walter
    Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial
    In: Oncology Research and Treatment, Jg. 45, 2022, Nr. 6, S. 319 – 325
    DOI (Open Access)
  • Grünwald, Viktor; Bergmann, Lars; Brehmer, B.; Eberhardt, B.; Kastrati, Karin; Gauler, Thomas; Gehbauer, G.; Gschwend, J.; Johannsen, M.; Klotz, T.; Protzel, C.; Schenck, Marcus; Staehler, M.
    Systemic therapy in metastatic renal cell carcinoma (mRCC) : an evidence-based recommendation of the German interdisciplinary RCC guidelines group
    In: World Journal of Urology, Jg. 40, 2022, Nr. 10, S. 2381 – 2386
    DOI (Open Access)
  • Sebastian, Martin; Fischer, Rieke N.; Reck, Martin; Binninger, Adrian; Hipper, Annette; Gauler, Thomas C.; Waller, Cornelius F.
    Behandlungsrealität des kleinzelligen Lungenkarzinoms in Deutschland – das CRISP-Register
    In: Der Onkologe, Jg. 27, 2021, Nr. 9, S. 911 – 916
    DOI
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gkika, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie E.; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal, Jg. 21, 2021, Nr. 2, S. 273
    DOI (Open Access)
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trial
    In: Radiation Oncology, Jg. 16, 2021, Nr. 1, S. 59
    DOI, Online Volltext (Open Access)
  • Nour, Youness; Pöttgen, Christoph; Kebir, Sied; Lazaridis, Lazaros; Lüdemann, Lutz; Guberina, Maja; Gauler, Thomas; Scheffler, Björn; Jabbarli, Ramazan; Pierscianek, Daniela; Sure, Ulrich; Schmidt, Teresa; Oster, Christoph; Hau, Peter; Glas, Martin; Lübcke, Wolfgang; Stuschke, Martin; Guberina, Nika
    Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial
    In: Journal of Applied Clinical Medical Physics, Jg. 22, 2021, Nr. 1, S. 242 – 250
    DOI, Online Volltext (Open Access)
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gikka, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal, Jg. 21, 2021, Nr. 1, S. 37 – 46
    DOI (Open Access)
  • Pogorzelski, Michael; Hilser, Thomas; Ting, Saskia; Kansy, Benjamin; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Grünwald, Viktor; Schuler, Martin; Kasper, Stefan
    Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
    In: Frontiers in Oncology, Jg. 11, 2021, 635096
    DOI, Online Volltext (Open Access)
  • Gauler, Thomas; von der Heyde, E.; Klautke, G.; von der Grün, J.; Tamaskovics, B.; Welslau, M.; Waldenberger, D.; Dietz, A.
    Investigation of the Effect of Radiotherapy Prior to Initiation of Treatment with Nivolumab in Patients with Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HSCCN) - Real-World Data from the non-interventional Study (NIS) HANNA
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 197, 2021, Nr. Suppl. 1, S. 107 – S108
  • Kürten, Cornelius H. L.; Zioga, Eleni; Gauler, Thomas; Stuschke, Martin; Guberina, Maja; Ludwig, Johannes M.; Deuss, Eric; Mattheis, Stefan; Lang, Stephan; Hussain, Timon
    Patterns of cervical lymph node metastasis in supraglottic laryngeal cancer and therapeutic implications of surgical staging of the neck
    In: European Archives of Oto-Rhino-Laryngology and Head & Neck, Jg. 278, 2021, Nr. 12, S. 5021 – 5027
    DOI (Open Access)
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin
    Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition
    In: Radiation Oncology, Jg. 16, 2021, Nr. 1, 176
    DOI, Online Volltext (Open Access)
  • Singh, Prianka; McDonald, Laura; Waldenberger, Daniela; Welslau, Manfred; von der Heyde, Eyck; Gauler, Thomas; Dietz, Andreas
    Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany
    In: Head and Neck, Jg. 43, 2021, Nr. 11, S. 3540 – 3551
    DOI (Open Access)
  • Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin
    Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1684 – 1691
    DOI, Online Volltext (Open Access)
  • Bergmann, Lothar; Grünwald, Viktor; Maute, Luise; Grimm, Marc-Oliver; Weikert, Steffen; Schleicher, Jan; Klotz, Theodor; Greiner, Jochen; Flörcken, Anne; Hartmann, Arndt; Gauler, Thomas
    A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma : An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society
    In: Oncology Research and Treatment, Jg. 43, 2020, Nr. 7-8, S. 333 – 338
    DOI (Open Access)
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Krebs, Bettina; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Jöckel, Karl-Heinz; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Eberhardt, Wilfried
    Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improve
    In: European Journal of Cancer (EJC), Jg. 138, 2020, S. 156 – 168
    DOI
  • Kirchner, Julian; Martin, Ole; Umutlu, Lale; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Swetlana; Gauler, Thomas; Theurer, Sarah; Antke, Christina; Esposito, Irene; Kinner, Sonja; Schaarschmidt, Benedikt M.; Kowall, Bernd; Lütke-Brintrup, Diana; Stang, Andreas; Becker, Anton S.; Antoch, Gerald; Buchbender, Christian
    Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithms
    In: European Journal of Radiology, Jg. 128, 2020, S. 108975
    DOI, Online Volltext (Open Access)
  • Motzer, Robert J.; Escudier, Bernard; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Plimack, Elizabeth R.; Procopio, Giuseppe; McDermott, David F.; Castellano, Daniel; Choueiri, Toni K.; Donskov, Frede; Gurney, Howard; Oudard, Stéphane; Richardet, Martin; Peltola, Katriina; Alva, Ajjai S.; Carducci, Michael; Wagstaff, John; Chevreau, Christine; Fukasawa, Satoshi; Tomita, Yoshihiko; Gauler, Thomas; Kollmannsberger, Christian K.; Schutz, Fabio A.; Larkin, James; Cella, David; McHenry, M. Brent; Saggi, Shruti Shally; Tannir, Nizar M.
    Nivolumab versus everolimus in patients with advanced renal cell carcinoma : Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
    In: Cancer, Jg. 126, 2020, Nr. 18, S. 4156 – 4167
    DOI, Online Volltext (Open Access)
  • Ivanyi, Philipp; Grüllich, Carsten; Kroeger, Nils; Gauler, Thomas; Johannsen, Manfred; Bedke, Jens; Grünwald, Viktor
    Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic : recommendations from the interdisciplinary working group for renal tumors (IAG-N)
    In: Journal of Cancer Research and Clinical Oncology, Jg. 146, 2020, Nr. 11, S. 3075 – 3078
    DOI (Open Access)
  • Haddad, Robert; Guigay, Joel; Keilholz, Ulrich; Clement, Paul M.; Fayette, Jérôme; de Souza Viana, Luciano; Rolland, Frédéric; Cupissol, Didier; Geoffrois, Lionnel; Kornek, Gabriela; Licitra, Lisa; Melichar, Bohuslav; Ribaldo Nicolau, Ulisses; Rauch, Daniel; Zanetta-Devauges, Sylvie; Cohen, Ezra E.W.; Machiels, Jean-Pascal; Tahara, Makoto; Vermorken, Jan; Geng, Yuan; Zografos, Eleftherios; Gauler, Thomas
    Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck : Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial
    In: Oral Oncology, Jg. 97, 2019, S. 82 – 91
    DOI
  • Burtness, Barbara; Haddad, Robert; Dinis, José; Trigo, José; Yokota, Tomoya; De Souza Viana, Luciano; Romanov, Ilya; Vermorken, Jan; Bourhis, Jean; Tahara, Makoto; Martins Segalla, José Getulio; Psyrri, Amanda; Vasilevskaya, Irina; Nangia, Chaitali Singh; Chaves-Conde, Manuel; Kiyota, Naomi; Homma, Akihiro; Holeckova, Petra; Del Campo, Josep Maria; Asarawala, Nirav; Nicolau, Ulisses Ribaldo; Rauch, Daniel; Even, Caroline; Wang, Bushi; Gibson, Neil; Ehrnrooth, Eva; Harrington, Kevin; Cohen, Ezra E. W.; Gauler, Thomas
    Afatinib vs Placebo as Adjuvant Therapy after Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck : A Randomized Clinical Trial
    In: JAMA Oncology, Jg. 5, 2019, Nr. 8, S. 1170 – 1180
    DOI (Open Access)
  • Pöttgen, Christoph; Kleinhans, J.; Gauler, Thomas; Wrede, Karsten; Schuler, Martin; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic Importance
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 195, 2019, Nr. Suppl. 1, S. S66 – S67
  • Klinghammer, Konrad; Gauler, Thomas; Dietz, Andreas; Grünwald, Viktor; Stöhlmacher, Jan; Knipping, Stephan; Schroeder, Marianne M.; Guntinas-Lichius, Orlando; Frickhofen, Norbert; Lindeman, H.-W.; Fietkau, Rainer; Haxel, Boris Rainer; Große-Thie, Christina; Maschmeyer, George; Zipfel, Matthias; Martus, Peter; Knoedler, Maren; Keilholz, Ulrich
    Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD) : an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)
    In: European Journal of Cancer (EJC), Jg. 122, 2019, S. 53 – 60
    DOI
  • Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann
    Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors : results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
    In: Journal of Cancer Research and Clinical Oncology, Jg. 145, 2019, Nr. 3, S. 717 – 723
    DOI
  • Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 7, S. 1439 – 1447
    DOI
  • Grünwald, Viktor; Eberhardt, Berit; Bex, Axel; Flörcken, Anne; Gauler, Thomas; Derlin, Thorsten; Panzica, Martin; Dürr, Hans Roland; Grötz, Knut Achim; Giles, Rachel H.; von Falck, Christian; Graser, Anno; Muacevic, Alexander; Staehler, Michael
    An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
    In: Nature Reviews Urology, Jg. 15, 2018, Nr. 8, S. 511 – 521
    DOI (Open Access)
  • Escudier, Bernard; Sharma, Padmanee; McDermott, David F.; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Procopio, Giuseppe; Plimack, Elizabeth R.; Castellano, Daniel; Gurney, Howard; Donskov, Frede; Peltola, Katriina; Wagstaff, John; Gauler, Thomas; Ueda, Takeshi; Zhao, Huanyu; Waxman, Ian M.; Motzer, Robert J.
    Erratum to “CheckMate 025 Randomized Phase 3 Study : Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma”
    In: European Urology, Jg. 73, 2018, Nr. 4, S. e116 – e118
    DOI
  • Mucha, M. A.; Abu Jawad, Jehad; Gauler, Thomas; Eberhardt, Wilfried; Guberina, M.; Stuschke, Martin; Pöttgen, Christoph
    Final Re-irradiation of Patients with NSCLC after primary high-dose Local Therapy
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 194, 2018, Nr. Suppl.1, S. S59
    DOI (Open Access)
  • Nadjm, S.; Pöttgen, Christoph; Gauler, Thomas; Exner, J. P.; Krebs, B.; Cheufou, D.; Umutlu, Lale; Deuschl, C.; Darwiche, Kaid; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive Effects
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 194, 2018, Nr. Suppl. 1, S. 110
    DOI (Open Access)
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 Study
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 194, 2018, Nr. Suppl.1, S. S41 – S42
    DOI (Open Access)
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Cheufou, D.; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trial
    In: Radiotherapy and Oncology (The Green Journal), Jg. 127, 2018, Nr. Suppl.1, S. S253 – S254
    DOI (Open Access)
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gauler, Thomas; Guberina, M.; Darwiche, Kaid; Aigner, Clemens; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 194, 2018, Nr. Suppl. 1, S. S23 – S24
    DOI (Open Access)
  • Cohen, Ezra E.W.; Licitra, L.F.; Burtness, B.; Fayette, J.; Gauler, Thomas; Clement, P.M.; Grau, J.J.; del Campo, J.M.; Mailliez, A.; Haddad, R.I.; Vermorken, J.B.; Tahara, M.; Guigay, J.; Geoffrois, L.; Merlano, M.C.; Dupuis, N.; Krämer, N.; Cong, X.J.; Gibson, N.; Solca, F.; Ehrnrooth, E.; Machiels, J.-P.H.
    Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
    In: Annals of Oncology, Jg. 28, 2017, Nr. 10, S. 2526 – 2532
    DOI (Open Access)
  • Escudier, Bernard; Sharma, Padmanee; McDermott, David F.; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Procopio, Giuseppe; Plimack, Elizabeth R.; Castellano, Daniel; Gurney, Howard; Donskov, Frede; Peltola, Katriina; Wagstaff, John; Gauler, Thomas; Ueda, Takeshi; Zhao, Huanyu; Waxman, Ian M.; Motzer, Robert J.
    CheckMate 025 Randomized Phase 3 Study : Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
    In: European Urology, Jg. 72, 2017, Nr. 6, S. 962 – 971
    DOI, Online Volltext (Open Access)
  • Mucha, M. A.; Pöttgen, Christoph; Moliavi, S.; Abu Jawad, Jehad; Gauler, Thomas; Christoph, Daniel; Eberhardt, Wilfried; Stuschke, Martin
    Factors for the long-term Survival of Patients with NSCLC in the Stage of oligometastatic Disease after definitive Local Therapy
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 193, 2017, Nr. Suppl. 1, S. 58
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Heinzelmann, F.; Cheufou, D.; Kimmich, M.; Friedel, G.; Schmidberger, H.; Darwiche, Kaid; Jendrossek, Verena; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trial
    In: Annals of Oncology, Jg. 28, 2017, Nr. 5, S. 1084 – 1089
    DOI (Open Access)
  • Diekstra, M.H.; Fritsch, A.; Kanefendt, F.; Swen, J.J.; Djar, Moes; Sörgel, Fritz; Kinzig, M.; Stelzer, C.; Schindele, D.; Gauler, Thomas; Hauser, S.; Houtsma, D.; Roessler, M.; Moritz, B.; Mross, K.; Bergmann, L.; Oosterwijk, E.; Kiemeney, L.A.; Guchelaar, H.J.; Jaehde, U.
    Population modeling integrating pharmacokinetics, pharmacodynamics, pharmacogenetics, and clinical outcome in patients with sunitinib-treated cancer
    In: CPT: Pharmacometrics and Systems Pharmacology, Jg. 6, 2017, Nr. 9, S. 604 – 613
    DOI (Open Access)
  • Pöttgen, Christoph; Guberina, M.; Abu Jawad, Jehad; Gauler, Thomas; Cordes, S.; Heinzelmann, F.; Schmidberger, H.; Darwiche, Kaid; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy Arm
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 193, 2017, Nr. 1, S. 20
  • Bedke, Jens; Gauler, Thomas; Grünwald, Viktor; Hegele, Axel; Herrmann, Edwin; Hinz, Stefan; Janssen, Jan; Schmitz, Stephan; Schostak, Martin; Tesch, Hans; Zastrow, Stefan; Miller, Kurt
    Systemic therapy in metastatic renal cell carcinoma
    In: World Journal of Urology, Jg. 35, 2017, Nr. 2, S. 179 – 188
    DOI (Open Access)
  • Schaarschmidt, Benedikt M; Grueneisen, Johannes; Metzenmacher, Martin; Gomez, Benedikt; Gauler, Thomas; Roesel, Christian; Heusch, Philipp; Ruhlmann, Verena; Umutlu, Lale; Antoch, Gerald; Buchbender, Christian
    Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to (18)F-FDG PET/CT?
    In: European Radiology, Jg. 27, 2017, Nr. 2, S. 681 – 688
    DOI
  • Roesel, Christian; Terjung, Sarah; Weinreich, Gerhard; Gauler, Thomas; Theegarten, Dirk; Stamatis, Georgios; Welter, Stefan
    A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine Carcinomas
    In: The Annals of Thoracic Surgery, Jg. 101, 2016, Nr. 5, S. 1909 – 1914
    DOI
  • Clement, P M; Gauler, Thomas; Machiels, J-P H; Haddad, R I; Fayette, J; Licitra, L F; Tahara, M; Cohen, E E W; Cupissol, D; Grau, J J; Guigay, J; Caponigro, F; de Castro, G; de Souza Viana, L; Keilholz, U; Del Campo, J M; Cong, X J; Ehrnrooth, E; Vermorken, J B
    Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma : subgroup analysis of the LUX-Head & Neck 1 trial
    In: Annals of Oncology, Jg. 27, 2016, Nr. 8, S. 1585 – 1593
    DOI (Open Access)
  • Motzer, R. J.; Sharma, P.; McDermott, D. F.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Procopio, G.; Plimack, E. R.; Castellano, D. E.; Gurney, H.; Donskov, F.; Bono, P.; Wagstaff, J.; Gauler, Thomas; Ueda, T.; Zhao, H. Y.; Waxman, I. M.; Escudier, B.
    CheckMate 025 phase III trial : Outcomes by key baseline factors and prior therapy for nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
    In: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 2 Suppl., S. 498
    DOI
  • Nel, Ivonne; Gauler, Thomas; Bublitz, Kira; Lazaridis, Lazaros; Goergens, André; Giebel, Bernd; Schuler, Martin; Hoffmann, Andreas-Claudius
    Circulating Tumor Cell Composition in Renal Cell Carcinoma
    In: PLoS ONE, Jg. 11, 2016, Nr. 4, e0153018
    DOI (Open Access)
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    In: Journal of Cancer Research and Clinical Oncology, Jg. 142, 2016, Nr. 4, S. 795 – 805
    DOI
  • Pöttgen, Christoph; Gauler, Thomas; Bellendorf, Alexander; Guberina, Maja; Bockisch, Andreas; Schwenzer, Nina; Heinzelmann, Frank; Cordes, Sebastian; Schuler, Martin H; Welter, Stefan; Stamatis, Georgios; Friedel, Godehard; Darwiche, Kaid; Jöckel, Karl-Heinz; Eberhardt, Wilfried; Stuschke, Martin
    Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung Cancer
    In: Journal of Clinical Oncology (JCO), Jg. 34, 2016, Nr. 21, S. 2526 – 2533
    DOI
  • Plimack, E. R.; Motzer, R. J.; Escudier, B.; Sharma, P.; Mcdermott, D. F.; George, S.; Hammers, H. J.; Carducci, M.; Tykodi, S. S.; Sosman, J. A.; Choueiri, T. K.; Donskov, F.; Gurney, H.; Gauler, Thomas; Ueda, T.; Zhao, H. Y.; Berghorn, E.; Wagstaff, J.
    Two-year efficacy and safety update from the phase III CheckMate 025 study of nivolumab versus everolimus in patients with advanced renal cell carcinoma (aRCC)
    In: BJU International (BJUI), Jg. 118, 2016, Nr. Suppl. 5, S. 11 – 12
    DOI
  • MacHiels, Jean Pascal H.; Specenier, Pol M.; Krauß, Jürgen C.; Dietz, A.; Kaminsky, Marie Christine; Lalami, Yassine; Henke, M.; Keilholz, Ulrich; Knecht, Rainald; Skartved, Niels Jörgen Østergaard; Horak, Ivan D.; Pamperin, P.; Braun, Stephan; Gauler, Thomas
    A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
    In: Cancer Chemotherapy and Pharmacology, Jg. 76, 2015, Nr. 1, S. 13 – 20
    DOI
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, Eleni; Freitag, Lutz; Lübcke, Wolfgang; Welter, Stefan; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin
    Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy
    In: Journal of Thoracic Disease, Jg. 7, 2015, Nr. 3, S. 264 – 272
    DOI
  • Machiels, Jean-Pascal H; Haddad, Robert I; Fayette, Jérôme; Licitra, Lisa F; Tahara, Makoto; Vermorken, Jan B; Clement, Paul M; Gauler, Thomas; Cupissol, Didier; Grau, Juan José; Guigay, Joël; Caponigro, Francesco; de Castro, Gilberto; de Souza Viana, Luciano; Keilholz, Ulrich; Del Campo, Joseph M; Cong, Xiuyu Julie; Ehrnrooth, Eva; Cohen, Ezra E W; LUX-H&N 1 investigators
    Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1) : an open-label, randomised phase 3 trial
    In: The Lancet Oncology, Jg. 16, 2015, Nr. 5, S. 583 – 594
    DOI
  • John, Katharina; Rösner, Imme; Keilholz, Ulrich; Gauler, Thomas; Bantel, Heike; Grünwald, Viktor
    Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients
    In: European Journal of Cancer (EJC), Jg. 51, 2015, Nr. 12, S. 1596 – 1602
    DOI
  • Cohen, E. E. W.; Licitra, L. F.; Fayette, J.; Gauler, Thomas; Clement, P. M.; Grau, J. J.; Del Campo, J. M.; Mailliez, A.; Haddad, R. I.; Vermorken, J. B.; Tahara, M.; Guigay, J.; Geoffrois, L.; Merlano, M. C.; Dupuis, N. F.; Burtness, B.; Gibson, N.; Solca, F.; Ehrnrooth, E.; Machiels, J. P. H.
    Biomarker analysis in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients (pts) treated with second-line afatinib versus methotrexate (MTX) : LUX-Head & Neck 1 (LUX-H&N1)
    In: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 15 Suppl., S. 6023
    DOI
  • Motzer, Robert J.; Escudier, Bernard; Mcdermott, David F.; George, Saby; Hammers, Hans J.; Srinivas, Sandhya; Tykodi, Scott S.; Sosman, Jeffrey A.; Procopio, Giuseppe; Plimack, Elizabeth R.; Castellano, Daniel; Gurney, Howard; Donskov, Frede; Bono, Petri; Wagstaff, John; Gauler, Thomas; Ueda, Takeshi; Xu, Li-An; Waxman, Ian M.; Sharma, Padmanee
    CheckMate 025 : a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)
    In: BJU International (BJUI), Jg. 116, 2015, Nr. S 5: Fourteenth International Kidney Cancer Symposium Miami Marriott Biscayne Bay, Miami, Florida 6–7 November 2015 : Abstracts, S. 17
    DOI
  • Schöffski, Patrick; Besse, Benjamin; Gauler, Thomas; de Jonge, Maja J.A.; Scambia, Giovanni M.; Santoro, Armando; Davite, Cristina; Jannuzzo, Maria Gabriella; Petroccione, Anna; Delord, Jean Pierre
    Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer : a multi-tumour, multi-institutional phase II study
    In: Annals of Oncology, Jg. 26, 2015, Nr. 3, S. 598 – 607
    DOI
  • Kruger, Stephan; Boeck, Stefan; Heinemann, Volker; Laubender, Rüdiger P.; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Geissler, Michael; Greten, Tim F.; Hegewisch-Becker, Susanna; Modest, Dominik P.; Stintzing, Sebastian; Haas, Michael
    Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer : a subgroup analysis from AIO-PK0104
    In: Acta Oncologica, Jg. 54, 2015, Nr. 7, S. 993 – 1000
    DOI (Open Access)
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, Stephan; Bergmann, Christoph; Brandau, Sven; Abu-Jawad, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies
    In: Oral Oncology, Jg. 51, 2015, Nr. 5, S. e39
    DOI
  • Motzer, Robert J; Escudier, Bernard; McDermott, David F; George, Saby; Hammers, Hans J; Srinivas, Sandhya; Tykodi, Scott S; Sosman, Jeffrey A; Procopio, Giuseppe; Plimack, Elizabeth R; Castellano, Daniel; Choueiri, Toni K; Gurney, Howard; Donskov, Frede; Bono, Petri; Wagstaff, John; Gauler, Thomas; Ueda, Takeshi; Tomita, Yoshihiko; Schutz, Fabio A; Kollmannsberger, Christian; Larkin, James; Ravaud, Alain; Simon, Jason S; Xu, Li-An; Waxman, Ian M; Sharma, Padmanee
    Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
    In: The New England Journal of Medicine, Jg. 373, 2015, Nr. 19, S. 1803 – 1813
    DOI
  • Joerger, Markus; Von Pawel, Joachim; Kraff, Stefanie; Fischer, Juergen R; Eberhardt, Wilfried; Gauler, Thomas; Mueller, Lothar; Reinmuth, Niels; Reck, Martin; Kimmich, Martin; Mayer, Frank; Kopp, Hans-Georg; Behringer, Dirk M.; Ko, Yon-Dschun; Frueh, Martin; Hilger, Ralf A.; Roessler, Max; Moritz, Berta; Jaehde, Ulrich
    Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer (NSCLC) patient
    In: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 15_suppl, S. 8051
    DOI, Online Volltext
  • Joerger, M.; Von Pawel, J.; Kraff, S.; Fischer, J. R.; Gauler, Thomas; Mueller, L.; Reinmuth, N.; Reck, M.; Kimmich, M.; Frank, M.; Kopp, H. G.; Behringer, D.; Ko, Y. D.; Ralf, H.; Roessler, M.; Kloft, C.; Henrich, A.; Moritz, B.; Jaehde, U.
    Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent : Updated results of the randomized CEPAC-TDM study
    In: European Journal of Cancer (EJC), Jg. 51, 2015, Nr. S3: Abstracts from the European Cancer Congress 2015, S. 618
    DOI
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Lütke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin
    Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
    In: Journal of Clinical Oncology (JCO), Jg. 33, 2015, Nr. 35, S. 4194 – 4201
    DOI
  • Pöttgen, Christoph; Stuschke, Martin; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, Eleni; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, Matthias; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
    In: BMC Cancer, Jg. 15, 2015, Nr. 1, S. 363
    DOI (Open Access)
  • Tahara, M.; Cohen, E. E. W.; Haddad, R. I.; Fayette, J.; Licitra, L. F.; Clement, P. M.; Vermorken, J. B.; Gauler, Thomas; Cupissol, D.; Grau, J. J.; Guigay, J.; del Campo, J. M.; Okami, K.; Takahashi, S.; Burtness, B.; Cong, X. J.; Gibson, N.; Solca, F.; Ehrnrooth, E.; Machiels, J. P. H.
    Second-line afatinib vs methotrexate (MTX) in patients (pts) with recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) : subgroup/biomarker analysis of LUX-head and neck 1 (LUX-H&N1)
    In: Annals of Oncology, Jg. 26, 2015, Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, S. 93
    DOI
  • Grünwald, Viktor; Keilholz, U; Böhm, Alexander; Guntinas-Lichius, O; Hennemann, B; Schmoll, H J; Ivanyi, P; Abbas, M; Lehmann, U; Koch, Achim; Karch, A; Zörner, A; Gauler, Thomas
    TEMHEAD : a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)
    In: Annals of Oncology, Jg. 26, 2015, Nr. 3, S. 561 – 567
    DOI (Open Access)
  • Saloura, Vassiliki; Cohen, Ezra E. W.; Licitra, Lisa; Billan, Salem; Dinis, Jose; Lisby, Steen; Gauler, Thomas
    An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
    In: Cancer Chemotherapy and Pharmacology, Jg. 73, 2014, Nr. 6, S. 1227 – 1239
    DOI
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D; O'Shannessy, Daniel J; Gauler, Thomas; Wohlschläger, Jeremias; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R
    Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients
    In: Clinical Lung Cancer, Jg. 15, 2014, Nr. 5, S. 320 – 330.e3
    DOI
  • Nel, Ivonne; Gauler, Thomas; Hoffmann, Andreas-Claudius
    Circulating tumor cell composition and outcome in patients with solid tumors
    In: International Journal of Clinical Pharmacology and Therapeutics, Jg. 52, 2014, Nr. 1, S. 74 – 75
    DOI
  • Vermorken, Jan B.; Peyrade, F.; Krauss, J.; Mesía, R.; Remenar, E.; Gauler, Thomas; Keilholz, U.; Delord, J. P.; Schafhausen, P.; Erfán, J.; Brümmendorf, T. H.; Iglesias, L.; Bethe, U.; Hicking, C.; Clement, P. M.
    Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck : Results of the randomized phase I/II ADVANTAGE trial (phase II part)
    In: Annals of Oncology, Jg. 25, 2014, Nr. 3, S. 682 – 688
    DOI (Open Access)
  • Weller, Patrick; Nel, Ivonne; Hassenkamp, Philipp; Gauler, Thomas; Schlüter, Anke; Lang, Stephan; Dountsop, Paulette; Hoffmann, Andreas-Claudius; Lehnerdt, Götz
    Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)
    In: PLoS ONE, Jg. 9, 2014, Nr. 12, e113706
    DOI (Open Access)
  • Breitenbücher, Frank; Hoffarth, Sandra; Worm, Karl; Cortes-Incio, Diana; Gauler, Thomas; Köhler, Jens; Herold, Thomas; Kurt Werner, Schmid; Freitag, Lutz; Kasper, Stefan; Schuler, Martin
    Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
    In: PLoS ONE, Jg. 9, 2014, Nr. 1, e85350
    DOI (Open Access)
  • Nensa, Felix; Stattaus, Jörg; Morgan, Bruno; Horsfield, Mark A.; Soria, Jean-Charles; Besse, Benjamin; Gounant, Valerie; Khalil, Antoine; Seng, Katja; Fischer, Berthold; Krissel, Heiko; Laurent, Dirk; Christoph, Daniel; Eberhardt, Wilfried; Gauler, Thomas
    Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer
    In: Future Oncology, Jg. 10, 2014, Nr. 5, S. 823 – 833
    DOI
  • Berger, Lars Arne; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Gauler, Thomas; Beyer, Jörg; Wit, Maike de; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin
    First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy : analysis of a registry of the German Testicular Cancer Study Group (GTCSG)
    In: Journal of Cancer Research and Clinical Oncology, Jg. 140, 2014, Nr. 7, S. 1211 – 1220
    DOI
  • Pogorzelski, M-; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, Christoph; Brandau, Sven; Abu Jawad, Jehad; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
    In: Cell Death and Disease, Jg. 5, 2014, Nr. 2, e1091
    DOI (Open Access)
  • Nel, Ivonne; Jehn, Ulrich; Gauler, Thomas; Hoffmann, Andreas-Claudius
    Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment
    In: Translational Lung Cancer Research, Jg. 3, 2014, Nr. 2, S. 100 – 106
    DOI (Open Access)
  • Gkika, E.; Gauler, Thomas; Eberhardt, Wilfried; Stahl, Michael; Stuschke, Martin; Pöttgen, Christoph
    Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus
    In: Diseases of the Esophagus, Jg. 27, 2014, Nr. 7, S. 678 – 684
    DOI
  • Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael L.; Sipos, Bence; Schlitter, Anna Melissa Elissa; Esposito, Iréne; Jung, Andreas; Laubender, Rüdiger Paul Aul; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael Roland; Gauler, Thomas; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas; Boeck, Stefan
    PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer : a translational subgroup analysis from AIO-PK0104
    In: BMC Cancer, Jg. 14, 2014, Nr. 1, 624
    DOI (Open Access)
  • Eberhardt, Wilfried; Gauler, Thomas; Pöttgen, Christoph; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Kimmich, M.; Fischer, B.; Schmidberger, H.; Gkika, E.; Cordes, S.; Hepp, R.; Luetke-Brintrup, D.; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin; ESPATUE AIO ARO Clinical Trials
    Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)
    In: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 15 Suppl., S. 7510
    DOI
  • Harbeck, Nadia; Solca, Flavio; Gauler, Thomas
    Preclinical and clinical development of afatinib : a focus on breast cancer and squamous cell carcinoma of the head and neck
    In: Future Oncology, Jg. 10, 2014, Nr. 1, S. 21 – 40
    DOI
  • Kordelas, L.; Bauer, Sebastian; Schuler, Martin; Beelen, Dietrich; Gauler, Thomas
    Successful resuscitation of a patient with ventricular fibrillation due to hypomagnesemia under cetuximab therapy
    In: TumorDiagnostik & Therapie, Jg. 35, 2014, Nr. 1, S. 25 – 27
    DOI
  • Maute, Luise; Grünwald, Viktor; Weikert, Steffen; Kube, Ulrich; Gauler, Thomas; Kahl, Christoph; Burkholder, Iris; Bergmann, Lothar
    Therapy of mRCC beyond mTOR-inhibition in clinical practice : results of a retrospective analysis
    In: Journal of Cancer Research and Clinical Oncology, Jg. 140, 2014, Nr. 5, S. 823 – 827
    DOI
  • Heusch, Philipp; Buchbender, Christian; Köhler, Jens; Nensa, Felix; Gauler, Thomas; Gomez, Benedikt; Reis, Henning; Stamatis, Georgios; Kühl, Hilmar; Hartung, Verena; Heusner, Till Alexander
    Thoracic staging in lung cancer : prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT
    In: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 3, S. 373 – 378
    DOI (Open Access)
  • Gauler, Thomas; Grünwald, Viktor
    Tumorrezidive der Kopf-Hals-Region nach Primärtherapie
    In: Der Onkologe, Jg. 20, 2014, Nr. 2, S. 152 – 158
    DOI
  • Funke, Faustina; Gauler, Thomas; Freitag, Lutz; Pöttgen, Christoph
    Using endobronchial valves to reduce irradiation portals in lung cancer : A case report
    In: Practical Radiation Oncology, Jg. 4, 2014, Nr. 1, S. e91 – e94
    DOI
  • Eberhardt, Wilfried; Gauler, Thomas; Lepechoux, C.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Welter, Stefan; Grunenwald, D.; Fischer, B.; Rodrigo, H. D.; Theegarten, Dirk; Le Chevalier, T.; Seeber, Siegfried; Stuschke, Martin; Pöttgen, Christoph
    10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)
    In: Lung Cancer, Jg. 82, 2013, Nr. 1, S. 83 – 89
    DOI
  • Pöttgen, Christoph; Eberhardt, Wilfried; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Wohlschläger, Jeremias; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin
    Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionation
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 9, S. 2107 – 2115
    DOI
  • Saloura, V.; Cohen, EEW; Licitra, L. F.; Billan, S.; Dinis, J.; Lisby, S.; Gauler, Thomas
    An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 15 Suppl., S. 6065
    DOI
  • Gauler, Thomas
    Biologische Therapie beim fortgeschrittenen Lungenkarzinom
    In: Deutsche Medizinische Wochenschrift - DMW, Jg. 138, 2013, Nr. 40, S. 2034 – 2036
    DOI
  • Heusch, Philipp; Buchbender, Christian; Köhler, Jens; Nensa, Felix; Beiderwellen, Karsten; Kühl, Hilmar; Lanzman, Rotem S.; Wittsack, Hans-Jörg; Gomez, Benedikt; Gauler, Thomas; Schuler, Martin; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Heusner, Till Alexander
    Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions : Initial results
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 185, 2013, Nr. 11, S. 1056 – 1062
    DOI
  • Boeck, Stefan; Jung, Andreas; Laubender, Rüdiger Paul; Neumann, Jens H.L.; Egg, Rosalind; Goritschan, Clara; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer Von Weikersthal, Ludwig; Clemens, Michael Roland; Gauler, Thomas; Märten, Angela; Klein, Stefan A.; Kojouharoff, Georgi; Barner, M.; Geissler, Michael; Greten, Tim F.; Mansmann, Ulrich R.; Kirchner, Thomas; Heinemann, Volker
    EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer : Translational results from the randomised, crossover phase 3 trial AIO-PK0104
    In: British Journal of Cancer (BJC), Jg. 108, 2013, Nr. 2, S. 469 – 476
    DOI (Open Access)
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 15, S. 3076 – 3082
    DOI
  • Oechsle, K.; Berger, L. A.; Lorch, A.; Hentrich, M.; Kopp, H. G.; Gauler, Thomas; Beyer, J.; De Wit, M.; Honecker, F.; Bokemeyer, C.
    First-salvage treatment in patients with recurrent or refractory advanced germ-cell cancer after cisplatin-based chemotherapy : A database of the German Testicular Cancer Study Group
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 15 Suppl., S. 4559
    DOI
  • Nel, I.; Gauler, Thomas; Eberhardt, Wilfried; Nickel, A. C.; Schuler, Martin; Thomale, Jürgen; Hoffmann, Andreas-Claudius
    Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment
    In: British Journal of Cancer (BJC), Jg. 109, 2013, Nr. 5, S. 1223 – 1229
    DOI (Open Access)
  • Rebmann, Vera; Gauler, Thomas; Schott, B.; Schott, P.; Bauer, Sebastian; Opalka, Bertram; Stamatis, Georgios; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter
    Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patients
    In: Tissue Antigens, Jg. 81, 2013, Nr. 5, S. 282 – 283
    DOI
  • Heinemann, Volker; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas; Weikersthal, Ludwig Fischer Von; Clemens, Michael R.; Geissler, Michael; Greten, Tim F.; Hegewisch-Becker, Susanna; Rubanovs, Oleg; Baake, Gerold; Höhler, Thomas; Ko, Yon D.; Jung, Andreas; Neugebauer, Sascha; Boeck, Stefan
    Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer : Final results of a randomised phase 3 trial of the 'arbeitsgemeinschaft internistische onkologie' (AIO-PK0104)
    In: Gut, Jg. 62, 2013, Nr. 5, S. 751 – 759
    DOI
  • Heusch, Philipp; Köhler, Jens; Wittsack, Hans-Jörg; Heusner, Till Alexander; Buchbender, Christian; Pöppel, Thorsten; Nensa, Felix; Wetter, Axel; Gauler, Thomas; Hartung, Verena; Lanzman, Rotem S.
    Hybrid [18F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI) : Preliminary results in non-small cell lung cancer (NSCLC)
    In: European Journal of Radiology, Jg. 82, 2013, Nr. 11, S. 2055 – 2060
    DOI
  • Schuler, Patrick; Hoffmann, Thomas; Gauler, Thomas; Bergmann, Christoph; Brandau, Sven; Lang, Stephan
    Immuntherapie von Kopf-Hals-Karzinomen : Aktuelle Entwicklungen
    In: HNO, Jg. 61, 2013, Nr. 7, S. 559 – 572
    DOI
  • Eberhardt, Wilfried; Gauler, Thomas; Schadendorf, Dirk
    Neue Entwicklungen in der Behandlung von soliden Tumoren mit zielgerichteten Medikamenten. Lunge, Niere, Melanom
    In: Der Onkologe, Jg. 19, 2013, Nr. 10, S. 821 – 834
    DOI
  • Knoedler, M.; Gauler, Thomas; Grünwald, Viktor; Matzdorff, A.; Schroeder, M.; Dietz, A.; Jordan, W. O.; Arnold, D.; Hennemann, B.; Hofele, C.; Weissinger, F.; Eberhardt, Wilfried; Keilholz, U.
    Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy : A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie
    In: Oncology, Jg. 84, 2013, Nr. 5, S. 284 – 289
    DOI
  • Gauler, Thomas; Besse, B.; Novello, S.; Smit, E. F.; Plummer, E. R.; Delord, J. P.; Nicodemo, M.; Santoro, A.; Barone, C.; Marchetti, P.; Conte, P. F.; De Jonge, M. J.; Awada, A.; Mariani, M.; Jannuzzo, M. G.; Petroccione, A.; Ceruti, R.; Davite, C.; Eberhardt, Wilfried
    Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC)
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 15 Suppl., S. e19138
    DOI
  • Vermorken, J.B.; Licitra, L.; Stöhlmacher-Williams, J.; Dietz, A.; Lopez-Picazo, J.M.; Hamid, O.; Hossain, A.M.; Chang, S.-C.; Gauler, Thomas
    Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 13, S. 2877 – 2883
    DOI
  • Gauler, Thomas Christoph; Christoph, Daniel Christian; Fischer, Juergen; Frickhofen, Norbert; Huber, Rudolf; Gonschorek, Christine; Roth, Katrin; Giurescu, Marius; Eberhardt, Wilfried Ernst Erich
    Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancer
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 11, S. 2461 – 2468
    DOI
  • Boeck, S. H.; Ormanns, S.; Laubender, R. P.; Jung, A.; Siveke, Jens T.; Haas, M.; Neumann, J.; Vehling-Kaiser, U.; Winkelmann, C.; von Weikersthal, L. F.; Clemens, M. R.; Gauler, Thomas C.; Marten, A.; Klein, S.; Kojouharoff, G.; Geissler, M.; Greten, T. F.; Kirchner, T.; Heinemann, V.
    Phosphorylated ERK (pERK) as biomarker in patients with advanced pancreatic cancer treated with erlotinib within a randomized phase III trial (AIO-PK0104)
    2013 Gastrointestinal Cancers Symposium, January 24-26, 2013, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 4 Suppl., S. 189
    DOI
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D.; O'Shannessy, Daniel J.; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Hoiczyk, M.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
    In: Journal of Thoracic Oncology, Jg. 8, 2013, Nr. 1, S. 19 – 30
    DOI
  • Jaehde, U.; Hilger, Ralf A.; Gauler, Thomas; Sehrt, D.
    The 10th Annual Meeting of CESAR in Essen June 28 – 30, 2012, Germany
    In: International Journal of Clinical Pharmacology and Therapeutics, Jg. 51, 2013, Nr. 1, S. 34
    DOI
  • Vermorken, J. B.; Peyrade, F.; Krauss, J.; Mesia, R.; Remenar, E.; Gauler, Thomas; Keilholz, U.; Delord, J. P.; Schafhausen, P.; Erfan, J.; Brummendorf, T. H.; Iglesias, L.; Bethe, U.; de La Bourdonnaye, G.; Clement, P. M.
    Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck : The ADVANTAGE phase II trial
    In: Journal of Clinical Oncology (JCO), Jg. 30, 2012, Nr. Suppl. 15, S. 5516
  • Gauler, Thomas; Clement, P. M.; Peyrade, F.; Krauss, J.; Mesia, R.; Remenar, E.; Keilholz, U.; Delord, J. P.; Schafhausen, P.; Erfan, J.; Brummendorf, T. H.; Iglesias, L.; Bethe, U.; Hicking, C.; Vermorken, J. B.; ADVANTAGE Trial Grp
    Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck : the phase II ADVANTAGE trial
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 193 – 194
  • Christoph, Daniel; Hoffmann, Andreas-Claudius; Gauler, Thomas; Asuncion, Bernadette Reyna; Loewendick, Heike; Peglow, Anja; Hassan, Biftu; Tran, Cindy; Wynes, Murry W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 4, S. 766 – 767
    DOI (Open Access)
  • Pöttgen, Christoph; Levegrün, Sabine; Abu Jawad, Jehad; Lübcke, Wolfgang; Gkika, E.; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Effektivität und Toxizität von bildgeführter hochkonformaler Bestrahlung multipler zerebraler Metastasen mit/ohne Ganzhirnbestrahlung (WBRT) mittels helikaler Tomotherapie
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. 1 Suppl., S. 41 – 42
    DOI
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Kohlhaufl, M.; Hehr, T.; Budach, W.; Bamberg, M.; Welter, Stefan; Stamatis, Georgios; Fischer, B.; Eberhardt, Wilfried
    Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/Toxizitäten
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 34
    DOI
  • Christoph, Daniel; Asuncion, Bernadette Reyna; Mascaux, Celine; Tran, Cindy; Lu, Xian; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Theegarten, Dirk; Neumann, Volker; Hepp, Rodrigo; Welter, Stefan; Stamatis, Georgios; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 9, S. 1440 – 1448
    DOI (Open Access)
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Vossebein, I.; Breitenbucher, F.; Lang, Stephan; Hoffmann, T. K.; Bergmann, Christoph; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximab
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 193 – 193
  • Pöttgen, Christoph; Graupner, B.; Abu Jawad, Jehad; Gauler, Thomas; Theegarten, Dirk; Wohlschläger, Jeremias; Freitag, Lutz; Welter, Stefan; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 96 – 96
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based Chemotherapy
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 9, Suppl. 4, S. S211 – S212
  • Abu Jawad, Jehad; Pöttgen, Christoph; Levegrün, Sabine; Erichsen, Patricia; Gauler, Thomas; Lang, Stephan; Stuschke, Martin
    Langzeitergebnisse nach Re-Radiotherapie bei Patienten mit einem Tumorrezidiv bzw. Zweitkarzinom im Kopf-Hals-Bereich
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 188, 2012, Nr. Suppl. 1, S. 52
    DOI
  • Gauler, Thomas; Besse, Benjamin; Mauguen, Audrey; Méric, Jean Baptiste; Gounant, Valérie; Fischer, Berthold M.; Overbeck, Tobias R.; Krissel, Heiko; Laurent, Dirk; Tiainen, Marianne; Commo, Frédéric; Soria, Jean-Charles; Eberhardt, Wilfried
    Phase II trial of ptk787/zk 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage iiib/iv non-small-cell lung cancer (nsclc)
    In: Annals of Oncology, Jg. 23, 2012, Nr. 3, S. 678 – 687
    DOI
  • Trarbach, Tanja; Schultheis, Beate; Gauler, Thomas; Schneider, Vesile; Strumberg, Dirk; Eberhardt, Wilfried; Le Scouiller, Stephanie; Marotti, Marcelo; Brown, Kathryn H.; Drevs, Joachim
    Phase i open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
    In: Investigational New Drugs: The Journal of New Anticancer Agents, Jg. 30, 2012, Nr. 5, S. 1962 – 1971
    DOI
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wohlschläger, Jeremias; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapy
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 34
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 204 – 204
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: British Journal of Cancer (BJC), Jg. 107, 2012, Nr. 5, S. 823 – 830
    DOI (Open Access)
  • Pöttgen, Christoph; Le Pechoux, C.; Gauler, Thomas; Stuschke, Martin; Grunenwald, D. H.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Christoph, Daniel; Welter, Stefan; Fischer, B.; Hepp, R.; Theegarten, Dirk; Eberhardt, Wilfried
    10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)
    In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 494
  • Hepp, R.; Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Bildat, Stephan; Stamatis, Georgios; Seeber, S.; Wilke, Hansjochen; Budach, V.; Stuschke, Martin; Eberhardt, Wilfried
    15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIM
    In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S.S 492 - S493
  • Schmittel, Alexander; Sebastian, Martin; Fischer von Weikersthal, Ludwig; Martus, Peter; Gauler, Thomas; Kaufmann, Caroline; Hortig, Patricia; Fischer, Jürgen Richard; Link, Hartmut; Binder, Daniel; Fischer, Berthold; Caca, Karel; Eberhardt, Wilfried; Keilholz, Ulrich
    A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
    In: Annals of Oncology, Jg. 22, 2011, Nr. 8, S. 1798 – 1804
    DOI (Open Access)
  • Deutschbein, T.; Unger, Nicole; Yüce, Ali; Eberhardt, Wilfried; Gauler, Thomas; Lahner, Harald; Mann, Klaus; Petersenn, Stephan
    Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center Experience
    In: Hormone and Metabolic Research, Jg. 43, 2011, Nr. 12, S. 838 – 843
    DOI
  • Schuler, Patrick J; Börger, Verena; Bölke, Edwin; Habermehl, D; Matuschek, Christiane; Wild, Clarissa A.; Greve, Jens; Bas, Murat; Schilling, Bastian; Bergmann, Christoph; Trellakis, Sokratis; Budach, Wilfried; Gauler, Thomas; Brandau, Sven; Lang, Stephan; Whiteside, Theresa L.; Sorg, Rüdiger Volker; Hoffmann, Thomas
    Dendritic cell generation and CD4+CD25HIGHFOXP3+regulatory regulatory t cells in human head and neck carcinoma during radio-chemotherapy
    In: European Journal of Medical Research, Jg. 16, 2011, Nr. 2, S. 57 – 62
    DOI (Open Access)
  • Christoph, Daniel; Gauler, Thomas; Engelhard, M.; Theegarten, Dirk; Pöttgen, Christoph; Hepp, R.; Schuler, Martin; Hirsch, F.; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)
    In: European Journal of Cancer (EJC), Jg. 47, 2011, Nr. Suppl. 4, S. 14
  • Tinhofer, Ingeborg; Klinghammer, Konrad; Weichert, Wilko; Knödler, Maren; Stenzinger, Albrecht; Gauler, Thomas; Budach, Volker; Keilholz, Ulrich
    Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment
    In: Clinical Cancer Research, Jg. 17, 2011, Nr. 15, S. 5197 – 5204
    DOI
  • Pöttgen, Christoph; Levegrun, S.; Abu Jawad, Jehad; Wittig, Andrea; Hepp, R.; Gkika, E.; Grannaß, Andreas; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Hypofractionated image-guided radiotherapy (HF-IGRT) cerebral metastases by means of helical Tomotherapy
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 187, 2011, Nr. Suppl. 1, S. 19 – 19
  • Tinhofer, I.; Klinghammer, K. F.; Weichert, W.; Knoedler, M.; Stenzinger, A.; Gauler, Thomas; Budach, V.; Keilholz, U.
    Interference of amphiregulin and EGFRvIII expression with outcome of patients with squamous cell carcinoma of the head and neck (SCCHN) receiving cetuximab-docetaxel treatment
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 5508
    DOI
  • Gauler, Thomas; Pöttgen, Christoph; Wagner, H.; Korfee, Sönke; Hepp, R.; Stamatis, Georgios; Pawel, J. von; Passlick, B.; Budach, V.; Wilke, Hansjochen; Seeber, S.; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7042
    DOI
  • Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Wagner, H.; Hepp, R.; Stamatis, Georgios; Christoph, Daniel; Passlick, B.; Budach, V.; Seeber, S.; Wilke, Hansjochen; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VE
    In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 495
  • Eberhardt, Wilfried; Gauler, Thomas; Le Pechoux, C.; Hepp, R.; Welter, Stefan; Fischer, B.; Bildat, Stephan; Grunenwald, D.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph
    Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7047
    DOI
  • Hepp, R.; Pöttgen, Christoph; Gauler, Thomas; Erichsen, Patricia; Le Pechoux, C.; Grunenwald, D.; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 187, 2011, Nr. Suppl. 1, S. 68 – 69
  • Boeck, S. H.; Jung, A.; Laubender, R. P.; Neumann, J.; Egg, R.; Goritschan, C.; Vehling-Kaiser, U.; Winkelmann, C.; Fischer von Weikersthal, L.; Clemens, M. R.; Gauler, Thomas; Marten, A.; Klein, S.; Kojouharoff, G.; Barner, M.; Geissler, M.; Greten, T. F.; Mansmann, U.; Kirchner, T.; Heinemann, V.
    Molecular markers of the EGFR pathway in erlotinib-treated patients with advanced pancreatic cancer (APC) : Translational analyses of a randomized, cross-over AIO phase III trial
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 4047
    DOI
  • Eberhardt, Wilfried; Gauler, Thomas; Welter, Stefan; Krbek, Thomas; Stuschke, Martin; Pöttgen, Christoph
    Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen Lungenkarzinoms
    In: Der Onkologe, Jg. 17, 2011, Nr. 8, S. 691 – 701
    DOI
  • Christoph, DanielC; Mascaux, Celine; Wynes, MurryW; Asuncion, Bernadette; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Neumann, Volker; Pöttgen, Christoph; Tran, Cindy; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, FredR
    Predictive value of thymidylate synthase and Folypoly-Glutamate Synthease for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. Suppl. 6, S. S1092 – S1093
  • Christoph, Daniel; Mascaux, C.; Wynes, M. W.; Reyna Asuncion, B.; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7024
    DOI
  • Goeckenjan, G.; Sitter, Helmut; Thomas, Michael; Branscheid, Detlev; Flentje, Michael; Griesinger, Frank; Niederle, N.; Stuschke, Martin; Blum, Torsten; Deppermann, Karl-Matthias; Ficker, Joachim H.; Freitag, Lutz; Lübbe, Andreas Stephan; Reinhold, Thomas; Späth-Schwalbe, Ernst; Ukena, Dieter; Wickert, Martin; Wolf, M.; Andreas, Stefan; Auberger, Thomas; Baum, Richard Paul; Baysal, B.; Beuth, Joseph; Bickeböller, Heike; Böcking, Alfred; Bohle, Rainer Maria; Brüske, Irene; Burghuber, Otto; Dickgreber, Nicolas; Diederich, Stefan; Dienemann, Hendrick; Eberhardt, Wilfried; Eggeling, Stephan; Fink, Thomas; Fischer, Berthold; Franke, M.; Friedel, Godehard; Gauler, Thomas; Gütz, Sylvia; Hautmann, Hubert; Hellmann, Andreas; Hellwig, Dirk; Herth, Felix; Heußel, Claus Peter; Hilbe, Wolfgang; Hoffmeyer, Frank; Horneber, Markus; Huber, Rudolf Maria; Hübner, Jutta; Kauczor, Hans Ulrich; Kirchbacher, Klaus; Kirsten, Detlef; Kraus, Thomas; Lang, Susanne Maria; Martens, Uwe Marc; Mohn-Staudner, Andrea; Müller, Klaus Michael; Müller-Nordhorn, Jacqueline; Nowak, Dennis Alexander; Ochmann, Uta; Passlick, Bernward; Petersen, Iver; Pirker, Robert; Pokrajac, Boris; Reck, Martin; Riha, Susanne; Rübe, Christian; Schmittel, Alexander; Schönfeld, Nicolas; Schütte, Wolfgang; Serke, Monika; Stamatis, Georgios; Steingräber, Maria; Steins, Martin; Stoelben, Erich; Swoboda, Lothar; Teschler, Helmut; Tessen, Hans Werner; Weber, Matthias; Werner, Andreas; Wichmann, H.-E.; Irlinger Wimmer, E.; Witt, Christian; Worth, Heinrich
    Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged version
    In: Pneumologie, Jg. 65, 2011, Nr. 8, S. e51 – e75
    DOI
  • Heuer, Matthias; Kaiser, Gernot Maximil; Gauler, Thomas; Sheu, Sien-Yi; Kühl, Hilmar; Paul, Andreas
    Pseudomyxoma peritonei bei muzinösen Zystadenokarzinomen
    In: Gynäkologische Praxis, Jg. 35, 2011, Nr. 2, S. 273 – 280
  • Gauler, Thomas
    Renal cell carcinoma : Therapy management in Sequential therapy
    In: Aktuelle Urologie, Jg. 42, 2011, Nr. 3, S. A8 – A9
  • Christoph, Daniel; Wittkowski, Lukas; Stattaus, Jörg; Pöttgen, Christoph; Keyvani, Kathy; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried
    Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as Dementia
    In: Onkologie, Jg. 34, 2011, Nr. 6, S. 316 – 320
    DOI
  • Boeck, Stefan; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Marten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas; von Weikersthal, Ludwig Fischer; Clemens, Michael R.; Geissler, Michael; Greten, Tim F.; Hegewisch-Becker, Susanna; Neugebauer, Sascha; Heinemann, Volker
    Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer : an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'
    In: Anti-Cancer Drugs, Jg. 21, 2010, Nr. 1, S. 94 – 100
    DOI
  • Mönninghoff, Christoph; Maderwald, Stefan; Theysohn, Jens; Schütt, Philipp; Gauler, Thomas; Kraff, Oliver; Ladd, Mark E.; Ladd, Susanne; Wanke, Isabel
    Imaging of Brain metastases of bronchial carcinomas with 7 T MRI initial results
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 182, 2010, Nr. 9, S. 764 – 772
    DOI
  • Pöttgen, Christoph; Eberhardt, Wilfried; Gauler, Thomas; Krbek, Thomas; Berkovic, Katharina; Abu Jawad, Jehad; Korfee, Sönke; Teschler, Helmut; Stamatis, Georgios; Stuschke, Martin
    Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial
    In: International Journal of Radiation Oncology, Biology, Physics, Jg. 76, 2010, Nr. 3, S. 809 – 815
    DOI
  • Goeckenjan, Gerd; Sitter, Helmut; Thomas, Michael Byrne; Branscheid, Detlev; Flentje, Michael P.; Griesinger, Frank; Niederle, Norbert; Stuschke, Martin; Blum, Torsten G.; Deppermann, Karl Matthias; Ficker, Joachim H.; Freitag, Lutz; Lübbe, Andreas Stephan; Reinhold, Thomas; Späth-Schwalbe, Ernst; Ukena, Dieter; Wickert, M.; Wolf, Martin; Andreas, Stefan; Auberger, Thomas; Baum, Richard P.; Baysal, B.; Beuth, Joseph; Bickeböller, Heike; Böcking, Alfred H.; Bohle, Rainer Maria; Brüske, Irene; Burghuber, Otto C.; Dickgreber, Nicolas J.; Diederich, Stefan; Dienemann, Hendrik C.; Eberhardt, Wilfried; Eggeling, Stephan; Fink, Thomas H.; Fischer, Berthold M.; Franke, M.; Friedel, Godehard; Gauler, Thomas; Gütz, Sylvia; Hautmann, Hubert; Hellmann, Andreas; Hellwig, Dirk; Herth, Felix J.F.; Heußel, Claus Peter; Hilbe, Wolfgang; Hoffmeyer, Frank; Horneber, Markus A.; Huber, Rudolf Maria; Hübner, Jutta; Kauczor, Hans Ulrich; Kirchbacher, Klaus; Kirsten, Detlef K.; Kraus, Thomas; Lang, Susanne M.; Martens, Uwe M.; Mohn-Staudner, Andrea; Müller, Klaus Michael; Müller-Nordhorn, Jacqueline; Nowak, Dennis A.; Ochmann, Uta; Passlick, Bernward; Petersen, Iver; Pirker, Robert A.; Pokrajac, Boris; Reck, Martin; Riha, Susanne; Rübe, Christian E.; Schmittel, Alexander; Schönfeld, Nicolas; Schütte, Wolfgang; Serke, Monika; Stamatis, Georgios; Steingräber, Maria; Steins, Martin B.; Stoelben, Erich; Swoboda, Lothar; Teschler, Helmut; Tessen, Hans Werner; Weber, Martin R.; Werner, Andreas; Wichmann, Heinz-Erich; Irlinger Wimmer, E.; Witt, Christian; Worth, Heinrich
    Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
    In: Pneumologie, Jg. 64, 2010, Nr. Suppl. 2, S. e1 – e164
    DOI
  • Bauer, Sebastian; Mühlenberg, Thomas; Leahy, Michael; Hoiczyk, Mathias; Gauler, Thomas; Schuler, Martin; Looijenga, Leendert
    Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
    In: European Urology, Jg. 57, 2010, Nr. 4, S. 679 – 687
    DOI
  • Pöttgen, Christoph; Theegarten, Dirk; Eberhardt, Wilfried; Levegrün, Sabine; Gauler, Thomas; Krbek, Thomas; Stamatis, Georgios; Teschler, Helmut; Kuehl, Hilmar; Bockisch, Andreas; Stuschke, Martin
    Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer
    In: Oncology, Jg. 73, 2008, Nr. 5-6, S. 316 – 323
    DOI
  • Marra, Alex; Eberhardt, Wilfried; Pöttgen, Christoph; Theegarten, Dirk; Korfee, Sönke; Gauler, Thomas; Stuschke, Martin; Stamatis, Georgios
    Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
    In: European Respiratory Journal, Jg. 29, 2007, Nr. 1, S. 117 – 127
    DOI (Open Access)
  • Pöttgen, Christoph; Levegrün, Sabine; Theegarten, Dirk; Marnitz, Simone; Grehl, Sara; Pink, Roman; Eberhardt, Wilfried; Stamatis, Georgios; Gauler, Thomas; Antoch, Gerald; Bockisch, Andreas; Stuschke, Martin
    Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy
    In: Clinical Cancer Research, Jg. 12, 2006, Nr. 1, S. 97 – 106
    DOI

    • Abstracts

  • Dietz, A.; Hahn, D.A.; Langer, C.; Kubuschok, B.; Bockmühl, U.; Mueller-Huesmann, H.; Klautke, G.; Reuter, B.; Grün, J. von der; Beutner, D.; Büntzel, J.; Busch, C-J.; Tamaskovics, B.F.; Riera Knorrenschild, J.; Welslau, M.K.; Gauler, Thomas; Waldenberger, D.; Von der heyde, E.
    873P Nivolumab (NIVO) in the first-line (1L) or second-line (2L) and later (2L+) settings in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) : Updated results from the German non-interventional study (NIS), HANNA
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S625 – S626
    DOI
  • Grapatsas, K.; Doerr, F.; Oezkan, F.; Baldes, N.; Darwiche, Kaid; Theegarten, Dirk; Eberhardt, Wilfried; Gauler, Thomas; Stuschke, Martin; Hautzel, H.; Herrmann, Ken; Taube, Christian; Forsting, Michael; Schuler, Martin; Bölükbas, S.
    Impact of Preoperative Pulmonary Function on Survival Following Lobectomy for Stage I and II Lung Cancer
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 19, 2024, Nr. Suppl. 10, S. S531
  • Grapatsas, K.; Dörr, F.; Oezkan, F.; Baldes, N.; Theegarten, Dirk; Darwiche, Kaid; Eberhardt, Wilfried; Gauler, Thomas; Stuschke, Martin; Hautzel, H.; Herrmann, Ken; Taube, Christian; Forsting, Michael; Schuler, Martin; Bölükbas, S.
    The Influence of Smoking on Morbidity and Early Mortality after Anatomical Lung Resections for Stage I-IIIA NSCLC
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 19, 2024, Nr. Suppl. 10, S. S143 – S144
  • Khouya, Aymane; Santiago Garcia, Alina; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Lübcke, Wolfgang; Indenkämpen, Frank; Printz Ringbaek, Toke; Stuschke, Martin; Pöttgen, Christoph
    Adaptationszeit bestimmt den PTV-Margin : Analyse von 120 Fraktionen mit online adaptiver Strahlentherapie (ART) bei 6 Patienten mit Blasenkarzinom
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. 1 – 192
    DOI (Open Access)
  • Herz, Andreas; Guberina, Maja; Pöttgen, Christoph; Freisleben, Fabian; Hlouschek, Julian; Jendrossek, Verena; Wirsdörfer, Florian; Gauler, Thomas; Fischedick, Gerrit; Hoffmann, Christian; Stuschke, Martin; Guberina, Nika
    Gibt es unterschiedliche Verteilungsmuster zwischen strahlen- oder immuninduzierten Pneumonitiden in Abhängigkeit von der Dosisverteilung?
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S167 – S168
    DOI (Open Access)
  • Garcia, Alina Santiago; Khouya, Aymane; Gogishvili, Ana; Hoffmann, Christian; Alberti, Yasemin; Gauler, Thomas; Pöttgen, Christoph; Guberina, Maja; Guberina, Nika; Stuschke, Martin
    Inter- und intrafraktionale Variabilität der Position der ventralen Rektumwand bei Verwendung eines Rektumballons während der online adaptiven Strahlentherapie (oART) von Prostatakarzinomen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S143
    DOI (Open Access)
  • Richlitzki, Cedric; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Gauler, Thomas; Hautzel, Hubertus; Eberhardt, Wilfried; Darwiche, Kaid; Theegarten, Dirk; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    Kreuzvalidierte Prognoseparameter C-reaktives Protein und Blutbild-Parameter im Verlauf der kurativ intendierten Radiochemotherapie bei Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) im Stadium IIIA-C
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S100 – S101
    DOI (Open Access)
  • Fischedick, Gerrit; Sahin, Ezgi Ceren; Lübcke, Wolfgang; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ahmadipour, Yahya; Garcia, Alina Santiago; Zimmer, Lisa; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin; Pöttgen, Christoph
    Langzeitergebnisse nach hypofraktionierter ablativer Präzisionsbestrahlung bei Patienten mit multiplen cerebralen Metastasen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S124
    DOI (Open Access)
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Cordes, Sebastian; Metzenmacher, Martin; Brintrup, Diana Luetke; Guberina, Maja; Filiz, Özkan; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried
    Langzeitüberleben und konkurrierende Risiken von Patienten einer randomisierten Studie zur defnitiven vs. neoadjuvanten Radiochemotherapie + Resektion mit einem nach der Induktion resektablen NSCLC im Stadium III
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S7 – S8
    DOI (Open Access)
  • Hoffmann, Christian; Ringbaek, Toke; Garcia, Alina Santiago; Flühs, Andrea; Heintz, Martin; Lübcke, Wolfgang; Indenkämpen, Frank; Sauerwein, Wolfgang; Moliavi, Sourour; Pöttgen, Christoph; Gauler, Thomas; Guberina, Nika; Eckstein, Anja; Johansson, Patricia; Hüttmann, Andreas; Stuschke, Martin; Guberina, Maja
    Linsenschonende Elektronenbestrahlung bei konjunktivalen Non-Hodgkin Lymphomen : Monozentrische Langzeitdaten zur Efektivität und Nebenwirkungen
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S106
    DOI (Open Access)
  • Guberina, Maja; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Richlitzki, Cedric; Plönes, Till; Guberina, Nika; Forsting, Michael; Herrmann, Ken; Gauler, Thomas; Hoffmann, Christian; Theegarten, Dirk; Darwiche, Kaid; Garcia, Alina Santiago; Stuschke, Martin; Schuler, Martin
    Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S101 – S102
    DOI (Open Access)
  • Guberina, Nika; Guberina, Maja; Garcia, Alina Santiago; Ringbaek, Toke Printz; Pöttgen, Christoph; Khouya, Aymane; Hlouschek, Julian; Hoffmann, Christian; Herz, Andreas; Gauler, Thomas; Fischedick, Gerrit; Freisleben, Fabian; Stuschke, Martin
    Lässt sich die klassische IGRT durch online-onboard ART bei der Behandlung von Patienten mit Prostatakarzinom weiter verbessern?
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S52 – S53
    DOI (Open Access)
  • Pöttgen, Christoph; Guberina, Maja; Santiago, Alina; Indenkämpen, Frank; Lübcke, Wolfgang; Guberina, Nika; Gauler, Thomas; Alberti, Yasemin; Kiwitt, Lars Oliver; Ton, That Truong Mike; Aymane, Khouya; Stuschke, Martin
    Online-adaptative Strahlentherapie bei der kurativen Strahlentherapie von Lungentumoren in tiefer Inspiration, welche Bedeutung hat sie?
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S85
    DOI (Open Access)
  • Pöttgen, Christoph; Khouya, Aymane; Hoffmann, Christian; Gauler, Thomas; Guberina, Maja; Guberina, Nika; Ringbaek, Toke; Santiago, Alina; Krafft, Ulrich; Hadaschik, Boris; Stuschke, Martin
    Online-adaptive Strahlentherapie beim muskelinvasiven Blasenkarzinom mit angepassten PTVSäumen : Vorteil gegenüber der IGRT zum Zeitpunkt der Adaptation und gute akkumulierte EUD zum Zeitpunkt der Applikation
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S153
    DOI (Open Access)
  • Gauler, Thomas; Eberhardt, Wilfried; Martin, Sebastian
    PCI in der metastasierten Situation beim SCLC in real world : Daten aus der Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S97
    DOI (Open Access)
  • Bozorgmehr, F.; Weykamp, F.; Overbeck, T.R.; Maguire, N.; Buchmeier, E.L.; Hammer-Hellmig, M.; Gauler, Thomas C.; Wermke, M.; Troost, E.G.C.; Ulmer, M.; Mueller, A-C.; Kokowski, K.; Röper, B.; Wehler, T.; Hey-Koch, S.; Consdorf, N-S.; Behnisch, R.; Christopoulos, P.; Thomas, M.; Rieken, S.
    Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S1060
    DOI (Open Access)
  • Freisleben, Fabian; Guberina, Maja; Santiago Garcia, Alina; Printz Ringbaek, Toke; Pöttgen, Christoph; Khouya, Aymane; Hlouschek, Julian; Hoffmann, Christian; Herz, Andreas; Gauler, Thomas; Fischedick, Gerrit; Guberina, Nika; Stuschke, Martin
    Replizierbarkeit der Samenblasen-Lage bei der adaptiven Strahlentherapie (ART) des Prostatakarzinoms
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 199, 2023, Nr. Suppl. 1, S. S153
    DOI (Open Access)
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Schulte, C; Friedel, G.; Kopp, H.-G.; Fischer, B.; Schmidberger, H.; Kimmich, M.; Budach, W.; Cordes, S.; Metzenmacher, M.; de Los Rios, R. Hepp; Spengler, W.; De Ruysscher, D.; Belka, C.; Welter, S.; Brintrup, D. Luetke; Guberina, M.; Oezkan, F.; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin
    Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 17, 2022, Nr. 9, S. 65
    DOI
  • Guberina, M.; Pöttgen, Christoph; Lübcke, Wolfgang; Santiago Garcia, A.; Gauler, Thomas; Qamhiyeh, S.; Levegrün, Sabine; Guberina, N.; Indenkämpen, Frank; Stuschke, Martin
    Perspektiven für die tägliche adaptive online-onboard Strahlentherapie für Patientinnen mit Zervixkarzinom
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 198, 2022, Nr. Supplement 1, S. S25
    DOI (Open Access)
  • Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin
    Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 198, 2022, Nr. Supplement 1, S. S15
    DOI (Open Access)
  • Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin
    EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 142
  • Müller-Huesmann, H.; von der Heyde, E.; Hahn, D.; Langer, C.; Kubuschok, B.; Bockmühl, U.; Klautke, G.; Mauz, P-S.; Reuter, B.; Beutner, D.; Büntzel, J.; von der Grün, J.; Busch, C-J.; Tamaskovics, B.; Riera-Knorrenschild, J.; Gutsche, K.; Welslau, M.; Gauler, Thomas; Waldenberger, D.; Dietz, A.
    HANNA : Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. 813
    DOI (Open Access)
  • Fischedick, G.; Pöttgen, Christoph; Lübcke, Wolfgang; Gauler, Thomas; Guberina, M.; Guberina, N.; Pierscianek, D.; Livingstone, Elisabeth; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin
    Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical Irradiation
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 183
  • Hoffmann, C.; Mohr, Christopher; Johansson, Patricia; Dürig, Jan; Schmeling, C.; Bechrakis, N.; Eckstein, Anja; Manthey, A.; Pöttgen, Christoph; Gauler, Thomas; Guberina, N.; Müller, Andrea; Stuschke, Martin; Guberina, M.
    Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric Results
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 58 – S59
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the Esophagus
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 154 – S155
  • Pöttgen, Christoph; Gauler, Thomas; Guberina, M.; Pierscianek, D.; Wrede, Karsten; Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Stuschke, Martin
    Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. 176
  • Lauri, F.; Hilser, T.; Hense, Jörg; Ting, S. C.; Kansy, B.; Laue, K.; Gauler, Thomas C.; Stuschke, Martin; Schmid, K. W.; Lang, Stephan; Grünwald, Viktor; Schuler, Martin; Kasper, S.
    Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 58
    DOI (Open Access)
  • Guberina, Marko; Pöttgen, Christoph; Qamhiyeh, Sima; Santiago, Alina; Indenkämpen, Frank; Lübcke, Wolfgang; Gauler, Thomas; Chan, M.; Nour, Yassar; Guberina, Nika; Lüdemann, Lutz; Stuschke, Martin
    Atmungs-kontrollierte Radiotherapie (RT) bei der Behandlung von Patienten mit Lungentumoren : Vorteile der „Inspiratorybreath- hold“-RT gegenüber dem Gating in Exspiration abhängig von der Tumorlokalisation
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S42 – S43
    DOI (Open Access)
  • Klinghammer, Konrad Friedrich; Gauler, Thomas; Stromberger, Carmen; Kofla, Grzegorz; de Wit, Maike; Gollrad, Johannes; Rauer, Izabella; Martus, Peter; Tinhofer, Inge; Budach, Volker; Keilholz, Ulrich; Burock, Susen
    DURTRERAD : A phase II open-label study evaluating feasibility and efficacy of durvalumab (D) and durvalumab and tremelimumab (DT) in combination with radiotherapy (RT) in non-resectable locally advanced HPV-negative HNSCC—Results of the preplanned feasibility interim analysis
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. 15_Suppl., S. 6574
    DOI (Open Access)
  • Hahn, D.; Heyde, E. von der; Welslau, M.; Bockmühl, U.; Langer, C.; Müller-Huesmann, H.; Busch, C.-J.; Kubuschok, B.; Grün, J. von der; Riera-Knorrenschild, J.; Büntzel, J.; Gauler, Thomas; Waldenberger, D.; Dietz, A.
    Effectiveness and safety of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) - results from an observational study (HANNA) in Germany
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober2020,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 132
    DOI (Open Access)
  • Dietz, Andreas; Welslau, Manfred; Hahn, Dennis; Langer, Christine; Bockmühl, Ulrike; Müller-Huesmann, Harald; Busch, Chia-Jung; Riera-Knorrenschild, Jorge; Büntzel, Jens; Kubuschok, Boris; von der Grün, Jens; Gauler, Thomas; Waldenberger, Daniela; von der Heyde, Eyck
    HANNA : Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 38, 2020, Nr. 15_Suppl., S. 6532
    DOI (Open Access)
  • Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin
    Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143
    DOI (Open Access)
  • Pöttgen, Christoph; Plajer, D.; Gauler, Thomas; Guberina, Marko; Santiago, Alina; Guberina, Nika; Eberhardt, Wilfried; Schuler, Martin; Darwiche, Kaid; Plönes, Till; Aigner, Clemens; Stuschke, Martin
    Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher Intelligenz
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S57 – S58
    DOI (Open Access)
  • Gawish, Ahmed; Gauler, Thomas; Xydis, Kostis; Treckmann, Jürgen-Walter; Kasper-Virchow, Stefan; Pöttgen, Christoph; Stuschke, Martin
    Radiochemotherapie bei lokal fortgeschrittenen intra und extrahepatischen Gallenwegstumoren : niedriges Toxizitätsprofil bei hoch-konformalen Dosisverteilungen in Atem-getriggerter Bestrahlung
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S153
    DOI (Open Access)
  • Heyde, E. von der; Welslau, M.; Gauler, Thomas; Hahn, D.; Wittekindt, C.; Müller-Huesmann, H.; Bockmühl, U.; Mauz, P.-S.; Waldenberger, D.; Dietz, A.
    HANNA : real-world evidence from a German, prospective, non-interventional study with nivolumab in patients with squamous cell carcinoma of the head and neck (SCCHN)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 57
    DOI (Open Access)
  • Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
    61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,
    In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 105, 2019, Nr. 1, Supplement, S. S146 – S147
    DOI (Open Access)
  • Dietz, A.; Welslau, M.; Tometten, M. C.; Gauler, Thomas
    HANNA : A National, Prospective, Non-Interventional Study of Nivolumab (Nivo) in Patients (pts) with Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing On or After Platinum-Based Therapy
    33. Deutscher Krebskongress ; Perspektiven verändern Krebs – Krebs verändert Perspektiven, Diagnose – Therapie – (Über-)Leben ; 21. - 24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 14
    DOI (Open Access)
  • Welslau, Manfred; Gauler, Thomas; von der Heyde, E.; Dietz, Andreas
    HANNA : A national, prospective, non-interventional study of Nivolumab (Nivo) in patients (Pts) with squamous cell carcinoma of the head and neck (SCCHN) progressing on or after platinum-based therapy
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 306
    DOI (Open Access)
  • Exner, J.-P.; Nadjm, S.; Gauler, Thomas; Pöttgen, Christoph; Krebs, B.; Cheufou, D.; Darwiche, Kaid; Metzenmacher, M.; Theegarten, Dirk; Umutlu, Lale; Hoffmann, Andreas-Claudius; Oezkan, F.; Aigner, Clemens; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 109 – 110
    DOI (Open Access)
  • Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 108
    DOI (Open Access)
  • Sharma, P.; Tykodi, S. S.; Escudier, B.; Carducci, Michael; Oudard, S.; Hammers, H. J.; George, S.; Gauna, D. C.; Alva, A. S.; Richardet, M. E.; Chevreau, C.; Plimack, E. R.; Srinivas, S.; Procopio, G.; Sosman, J. A.; McDermott, D.; Choueiri, T. K.; Gauler, Thomas; Berghorn, E.; Yang, L.; Motzer, R.
    Three-Year Efficacy and Safety Update From the Phase III Checkmate 025 Study of Nivolumab (NIVO) v Everolimus (EVE) in Patients With Advanced Renal Cell Carcinoma (aRCC)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 78
    DOI (Open Access)
  • Pöttgen, Christoph; Abu Jawad, Jehad; Indenkampen, F.; Heintz, Martin; Ebenau, M.; Wienczierz, M.; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Vergleich der 3D-Navigation der atemabhängigen Tumor-Position mittels stereoskopischer Röntgenaufnahmen (ExacTrac) bzw. kV-ConeBeam-CTs bei der kurativen Radiotherapie von Lungenkarzinomen
    23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2017 ; 14. - 18. Juni 2017, Berlin, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 193, 2017, Nr. Suppl. 1: Abstracts DEGRO 2017, S. S79 – S80
    DOI
  • Pogorzelski, M.; Hilser, T.; Ting, Saskia; Vossebein, I.; Gauler, Thomas; Abendroth, A.; Lang, Stephan; Stuck, Boris; Abu-Jawad, J.; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 3, S. 307 – 308
    DOI
  • Cohen, E.; Licitra, L.; Burtness, B.; Fayette, J.; Gauler, Thomas; Clement, P. M.; Grau, J. J.; del Campo, J. M.; Mailliez, A.; Haddad, R. I.; Vermorken, J. B.; Tahara, M.; Guigay, J.; Geoffrois, L.; Merlano, M. C.; Cong, X. J.; Gibson, N.; Solca, F.; Ehrnrooth, E.; Machiels, J. P. H.
    Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX) : LUX-Head & Neck 1 (LHN1)
    2016 Multidisciplinary Head and Neck Cancer Symposium ; February 18-20, 2016, Scottsdale, Arizona, USA,
    In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 94, 2016, Nr. 4, S. 868 – 869
    DOI
  • Guberina, M.; Stuschke, Martin; Abu Jawad, Jehad; Gauler, Thomas; Gkika, E.; Bockisch, Andreas; Stamatis, Georgios; Eberhardt, Wilfried; Pöttgen, Christoph
    18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl.1, S. S21 – S22
    DOI
  • Sharma, P.; Escudier, B.; McDermott, D. F.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Procopio, G.; Plimack, E. R.; Castellano, D.; Gurney, H.; Donskov, F.; Bono, P.; Wagstaff, J.; Gauler, Thomas; Ueda, T.; Xu, L. A.; Waxman, I. M.; Motzer, R. J.
    CheckMate 025 : a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 51, 2015, Nr. S3: Abstracts from the European Cancer Congress 2015, S. 708
    DOI
  • Pöttgen, Christoph; Levegrun, S.; Abu Jawad, Jehad; Lübcke, Wolfgang; Wittig, Andrea; Grehl, Sara; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Ganzhirnbestrahlung (WBRT) versus Ganzhirnbestrahlung mit bildgeführter stereotaktischer Bestrahlung multipler cerebraler Metastasen mittels helikaler Tomotherapie – Toxizitätsanalyse einer randomisierten Studie
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl.1, S. 149
    DOI
  • Pöttgen, Christoph; Stuschke, Martin; Gauler, Thomas; Welter, Stefan; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. 36 – 37
    DOI
  • Joerger, M.; Salamone, S. J.; von Pawel, J.; Kraff, S.; Fischer, J. R.; Eberhardt, Wilfried; Gauler, Thomas; Muller, L.; Reinmuth, N.; Reck, M.; Kimmich, M.; Mayer, F.; Kopp, H. G.; Behringer, D. M.; Ko, Y. D.; Fruh, M.; Hilger, Ralf A.; Roessler, M.; Moritz, B.; Miller, Michael; Jaehde, U.
    Randomized study of individualized, pharmacokinetically-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 38, 2015, Nr. Suppl. 5, S. 14 – 14
    DOI
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. 23
    DOI
  • Fenner, Martin H.; Dieing, Annette; Oechsle, Karin; Hentrich, Marcus; Gauler, Thomas Christoph; Lorch, Anja; Kopp, Hans-Georg; Beyer, Joerg; Bokemeyer, Carsten; Gruenwald, Viktor; Honecker, Friedemann
    A single arm, open-label multicenter phase II trial of everolimus in patients with relapsed/refractory germ cell cancer (RADIT)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15, suppl., S. e15535
    DOI
  • Knoedler, M.; Gauler, Thomas; Dietz, A.; Grünwald, Viktor; Stoehlmacher-Williams, J.; Knipping, S.; Schroeder, M.; Guntinas-Lichius, O.; Frickhofen, N.; Lindemann, H.; Fietkau, R.; Haxel, B.; Junghanß, C.; Maschmeyer, G.; Zipfel, M.; Martus, P.; Keilholz, U.
    Cetuximab (C), Fluorouracil (F) and Cisplatin (P) Alone or with Docetaxel (D) for Recurrent/Metastatic (Rm) Head and Neck Cancer (Hnscc) : Final Analysis of Aio Trial # 1108 - Cefcid
    39th ESMO Congress (ESMO 2014), 26 – 30 September 2014, Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 25, 2014, Nr. Supplement 4, S. iv340
    DOI (Open Access)
  • Keilholz, Ulrich; Gauler, Thomas Christoph; Dietz, Andreas; Grünwald, Viktor; Stöhlmacher-Williams, Jan; Knipping, Stephan; Schröder, Michael; Guntinas-Lichius, Orlando; Frickhofen, Norbert; Lindemann, Hans Walter; Fietkau, Rainer; Haxel, Boris; Junghanss, Christian; Maschmeyer, Georg; Zipfel, Matthias; Martus, Peter; Knödler, Maren Kristina
    Cetuximab (C), fluorouracil (F), and cisplatin (P) alone or with docetaxel (D) for recurrent/metastatic (RM) head and neck cancer (HNSCC) : First analysis of AIO trial # 1108
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15, suppl., S. 6018
    DOI
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 226 – 227
    DOI
  • Gauler, Thomas; Nel, I.; Bublitz, K.; Lazaridis, L.; Schuler, Martin; Hoffmann, Andreas-Claudius
    Circulating tumor cell composition and molecular markers in metastasized renal cell carcinoma (mRCC)
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 131
    DOI
  • Jehn, U.; Nel, I.; Schuler, Martin; Gauler, Thomas; Hoffmann, Andreas-Claudius
    Circulating tumor cell subgroups and outcome in patients with non-small-cell-lung-cancer receiving platinum based treatment
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 89
    DOI
  • Gauler, Thomas; Espenhain, Lydia; Hoiczyk, Mathias; Nel, Ivonne; Parr, Annette; Roder, Joanna; Schuler, Martin H.; Eberhardt, Wilfried E. E.; Roder, Heinrich; Hoffmann, Andreas-Claudius
    Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohort
    50th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, 2014, Chicago, Illinois, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15 Suppl.
    DOI
  • Gkika, E.; Berkovic, Katharina; Abu Jawad, Jehad; Gauler, Thomas; Stahl, Michael; Stuschke, Martin; Pöttgen, Christoph
    DVH-Parameters and Toxicity of a dose increased Chemotherapy in locally advanced Squamous Cell Carcinoma (uT3/T4) of the Esophagus - Results of a prospective Phase I/II Study
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl.1, S. 109
    DOI
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
    56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,
    In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 90, 2014, Nr. 1, Supplement, S. S146 – S147
    DOI
  • Pöttgen, Christoph; Gkika, E.; Berkovic, Katharina; Abu Jawad, Jehad; Gauler, Thomas; Stahl, Michael; Stuschke, Martin
    Definitive Radio Chemo Therapy for locally advanced Squamous Cell Carcinoma (uT3/T4) of the Esophagus with increased dose Radiation Therapy - Results of a Phase I/II Study (SPOT)
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl.1, S. 36 – 37
    DOI
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Gkika, E.; Hepp, R.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl. 1, S. 5 – 6
    DOI
  • Gauler, Thomas; Pogorzelski, M.; Ting, Saskia; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Lang, Stephan; Bergmann, Christoph; Abu Jawad, Jehad; Markowetz, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 76
    DOI
  • Stuschke, Martin; Abu Jawad, Jehad; Eberhardt, Wilfried; Grehl, Sara; Pöttgen, Christoph; Arnold, G.; Pfortner, R.; Gauler, Thomas; Schmeling, C.; Mohr, Christopher
    Neoadjuvant Docetaxel/Cisplatin/5-FU based radiochemotherapy (RT-CT) increases pathologic complete remissions and survival of patients with locally advanced oral cavity carcinomas in comparison to RT-CT with cisplatin alone followed by resection : a long term observational study
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl.1, S. 79
    DOI
  • Abu Jawad, Jehad; Pöttgen, Christoph; Gauler, Thomas; Eberhardt, Wilfried; Arnold, G.; Grehl, Sara; Pfortner, R.; Schmeling, C.; Mohr, Christopher; Stuschke, Martin
    Neoadjuvante Radiochemotherapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Vergleich der Langzeitergebnisse zweier Protokolle
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl.1, S. 99 – 100
    DOI
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Kleinhans, J.; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl 1, S. 17
    DOI
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 190, 2014, Nr. Suppl. 1, S. 17
    DOI
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 2 – 3
    DOI
  • Pöttgen, Christoph; Eberhardt, Wilfried; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Wohlschläger, Jeremias; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin
    Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
    19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 19
    DOI
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Akzelerierte Post-Pneumonektomie Salvage-Bestrahlung (RTx) mit simultaner Chemotherapie (CTx) bei Patienten mit kontralateralen zentralen Lungenkarzinomrezidiven
    DEGRO 2013 19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 67
    DOI
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Kohlhaufl, M.; Hehr, T.; Budach, W.; Bamberg, M.; Welter, Stefan; Stamatis, Georgios; Fischer, B.; Jöckel, Karl-Heinz; Eberhardt, Wilfried
    Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : lassen sich Patienten lieber operieren?
    19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 87
    DOI
  • Nel, I.; Gauler, Thomas; Nickel, A.; Eberhardt, Wilfried; Thomale, Jürgen; Schuler, Martin; Hoffmann, A.
    Prä-therapeutische ex-vivo Reparatur Kinetiken von Cisplatin-DNA-Addukten in Zirkulierenden Tumorzellen als Platin-Resistenz Test
    119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden,
    In: Der Internist. Berlin: Springer Medizin, Jg. 54, 2013, Nr. Suppl. 1, S. 95 – 96
    DOI
  • Abu Jawad, Jehad; Grehl, Sara; Pöttgen, Christoph; Pfoertner, R.; Eberhardt, Wilfried; Gauler, Thomas; Arnold, G.; Mohr, Christopher; Stuschke, Martin
    Vergleich einer neoadjuvanten Radiochemotherapie mit Docetaxel/Cisplatin/5-FU oder mit Cisplatin alleine beim lokal fortgeschrittenen Mundhöhlenkarzinom
    19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 189, 2013, Nr. Suppl. 1, S. 100
    DOI
  • Theegarten, Dirk; Gauler, Thomas; Graupner, B.; Pöttgen, Christoph; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried; Freitag, Lutz; Welter, Stefan; Abu Jawad, Jehad
    Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy
    54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, MA, USA,
    In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 84, 2012, Nr. 3, Supplement, S. S154
    DOI
  • Pöttgen, Christoph; Goer, S.; Koitsch, R.; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Einfluss der Induktions-Chemotherapie auf die Parameter der hochdosierten Radiochemotherapie beim lokal fortgeschrittenen Lungenkarzinom
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 188, 2012, Nr. 1 Suppl., S. 96
    DOI
  • Christoph, Daniel C.; Asuncion, Bernadette Reyna; Wynes, Murry; Gauler, Thomas C.; Wohlschläger, Jeremias; Theegarten, Dirk; Welter, Stefan; Tran, Cindy; Hassan, Biftu; Loewendick, Heike; Peglow, Anja; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 72, 2012, Nr. 8, Suppl., S. 1713
    DOI
  • Köhler, Jens; Worm, K.; Gauler, Thomas; Hoiczyk, M.; Theegarten, Dirk; Eberhardt, Wilfried; Hense, Jörg; Breitenbücher, Frank; Schmid, Kurt Werner; Schuler, Martin
    Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) : a single center experience
    37th ESMO Congress, 28 September - 2 October 2012, Vienna, Austria,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 23, 2012, Nr. Suppl. 9, S. 437 – 438
    DOI
  • Grehl, Sara; Eberhardt, Wilfried; Pöttgen, Christoph; Abu Jawad, Jehad; Kaelberlah, Hans-Peter; Gauler, Thomas; Arnold, G.; Mohr, Christopher; Stuschke, Martin
    Neoadjuvante Therapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Induktionschemotherapie mit Docetaxel/Cisplatin/5-FU gefolgt von simultaner Strahlentherapie plus Docetaxel/Cisplatin gefolgt von OP – Phase-I-Studie: Ergebnisse und 3J-FU
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 188, 2012, Nr. 1 Suppl., S. 90 – 90
    DOI
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin
    Postpneumonectomy Radical Accelerated (Re-)irradiation and Concurrent Chemotherapy for Patients With Contralateral Central Lung Cancer Relapses
    54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, USA,
    In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 84, 2012, Nr. 3, Supplement, S. S598
    DOI
  • Eberhardt, Wilfried; Hepp, R.; Gauler, Thomas; Christoph, Daniel; Hoffmann, Andreas-Claudius; Theegarten, Dirk; Welter, Stefan; Schmid, Kurt Werner; Wohlschläger, Jeremias; Passlick, B.; Le Pechoux, C.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph
    Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
    14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S376 – S377
  • Abu Jawad, Jehad; Pöttgen, Christoph; Levegrün, Sabine; Erichsen, Patricia; Gauler, Thomas; Lehnerdt, Götz; Lang, Stephan; Stuschke, Martin
    Re-Radiotherapie bei Patienten mit einem Tumorrezidiv bzw. Zweitkarzinom im Kopfhalsbereich
    DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 187, 2011, Nr. Suppl. 1, S. 28
    DOI
  • Pöttgen, Christoph; Gkika, Eleni; Berkovic, Katharina; Kaelberlah, Hans-Peter; Abu Jawad, Jehad; Trarbach, Tanja; Gauler, Thomas; Stahl, Michael; Stuschke, Martin
    Dosisgesteigerte Strahlentherapie nach PET/CT-Planung in Kombination mit Induktions- und Simultaner Chemotherapie bei lokal fortgeschrittenen Platten-epithelkarzinomen (uT3/T4) des Ösophagus : Ergebnisse einer Phase I/II Studie (SPOT)
    16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 186, 2010, Nr. Suppl. 1, S. 48
    DOI
  • Eberhardt, Wilfried; Gauler, Thomas; W German Tumour Ctr
    Neoadjuvant therapy in stage III
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 7, S. 102 – 103
    DOI
  • Gauler, Thomas; Eberhardt, Wilfried
    Peritoneal mesothelioma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 12 – 13
    DOI
  • Hoffmann, Andreas-Claudius; Gauler, Thomas; Parr, A.; Eberhardt, Wilfried; Schuler, Martin
    Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer
    2010 ASCO Annual Meeting, June 4-8, 2010, Chicago, Ill., USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 28, 2010, Nr. 15, Suppl., 7512
  • Stattaus, Jörg; Kalkmann, J.; Gauler, Thomas; Köhler, Jens; Lauenstein, Thomas; Forsting, Michael; Ladd, Susanne
    Whole-body MRI in staging of Small cell Lung cancer (SCLC) : Detection of Bone metastases and that Osteoblastic Response - Phenomenon
    29. Deutscher Krebskongress, 24.-27. Februar 2010, Berlin, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 2, S. 123
    DOI
  • Doehn, C.; Rebmann, U.; Gauler, Thomas; Kamann, L.; Detsch, C.; Albrecht, M.; Jager, E.
    Zukunft der Therapie von Patienten mit metastasiertem Nierenzellkarzinom – Kombinationstherapie oder beste Therapiesequenz?
    In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 2, S. 91
    DOI

    • Poster / Posterbeiträge

  • Kubuschok, B.; von der Heyde, E.; Hahn, D.A.; Langer, C.; Bockmühl, U.; Mueller-Huesmann, H.; Klautke, G.; Mauz, P-S.; Reuter, B.; von der Grün, J.; Beutner, D.; Büntzel, J.; Busch, C-J.; Tamaskovics, B.F.; Riera Knorrenschild, J.; Welslau, M.K.; Gauler, Thomas C.; Waldenberger, D.; Dietz, A.
    Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany : Updated results from the real-world HANNA study
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S584 – S585
    DOI (Open Access)
  • Sebastian, M.; Reck, M.; Fischer, R.; Christoph, D. C.; Bernhardt, C.; von der Heyde, E.; Nusch, A.; Ludwig, P.; Hipper, A.; Hanselmann, J.; Medinger, T.; Binninger, A.; Jänicke, M.; Christopoulos, P.; Elender, C.; Bethge, A.; Seese, B.; Gauler, Thomas; Waller, C. F.
    Erste Real-World Outcome-Daten von Patienten mit SCLC in Deutschland : Daten aus der Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 96
    DOI (Open Access)
  • Sebastian, M.; Reck, M.; Fischer, R.N.; Christoph, D.C.C.; Bernhardt, C.; von der Heyde, E.; Nusch, A.; Ludwig, P.; Hipper, A.; Hanselmann, J.; Medinger, T.; Binninger, A.; Jänicke, M.; Christopoulos, P.; Elender, C.; Bethge, A.; Seese, B.; Gauler, Thomas C.; Waller, C.
    First real-world outcome data of SCLC in Germany : Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)
    ESMO Congress 2022 ; 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1252
    DOI (Open Access)
  • Langer, C.; von der Heyde, E.; Hahn, D.A.; Kubuschok, B.; Bockmühl, U.; Mueller-Huesmann, H.; Klautke, G.; von der Grün, J.; Beutner, D.; Büntzel, J.; Busch, C-J.; Tamaskovics, B.F.; Riera Knorrenschild, J.; Gutsche, K.; Welslau, M.K.; Gauler, Thomas C.; Waldenberger, D.; Dietz, A.
    HANNA : Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 33, 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S854
    DOI (Open Access)
  • Pogorzelski, M.; Fendler, Wolfgang; Berliner, C.; Hussain, T.; Lang, Stephan; Ting, Saskia; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Gauler, Thomas; Stuschke, Martin; Laue, K.; Herrmann, Ken; Grünwald, Viktor; Schuler, Martin; Kasper-Virchow, S.
    Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 230 – 231
    DOI (Open Access)
  • Pöttgen, Christoph; Santiago, A.; Guberina, M.; Indenkämpen, Frank; Qamhiyeh, S.; Guberina, N.; Lübcke, Wolfgang; Gauler, Thomas; Tschirdewahn, Stephan; Stuschke, Martin
    Klinisch-dosimetrische Aspekte der Online-Planadaptation bei der kurativen Strahlentherapie lokal begrenzter urogenitaler Tumore : erste Erfahrungen mit dem Ethos®- System
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 198, 2022, Nr. Supplement 1, S. S71 – S72
    DOI (Open Access)
  • Hoffmann, C.; Guberina, M.; Pöttgen, Christoph; Gauler, Thomas; Guberina, N.; Stuschke, Martin
    MRT-morphologische Charakteristika von niedrig malignen, orbitalen Non-Hodgkin Lymphomen nach kurativ intendierter Strahlentherapie : Bildgebende Remissionskriterien in der Langzeitbeobachtung
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 198, 2022, Nr. Supplement 1, S. S129
    DOI (Open Access)
  • Pogorzelski, M.; Lauri, F.; Hilser, T.; Hense, Jörg; Ting, Saskia; Kansy, B.; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Zaun, G.; Grünwald, Viktor; Schuler, Martin; Kasper, Stefan
    Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
    ESMO Congress 2021, 16 – 21 September 2021, Virtual,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. S812
    DOI (Open Access)
  • Gauler, Thomas; Ottinger, Hellmut; Basu, Oliver; Pöttgen, Christoph; Guberina, M.; Guberina, N.; Trenschel, Rudolf; Reinhardt, Dirk; Stuschke, Martin
    Modification of total nodal Irradiation (TNI) as Part of Conditioning prior to allogeneic Stem Cell Transplantation (aSCT) for hematological Diseases using helical Tomotherapy or IMRT based on a retrospective Cohort
    27. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, DEGRO 2021, virtuell,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1: Abstracts DEGRO 2021, S. S173
    DOI (Open Access)
  • Gauler, Thomas; Ottinger, Hellmut; Basu, Oliver; Pöttgen, Christoph; Guberina, Marko; Guberina, N.; Trenschel, Rudolf; Reinhardt, Dirk; Beelen, Dietrich; Stuschke, Martin
    Modifikation der total nodalen Bestrahlung (TNI) als Teil der Konditionierung vor allogener Stammzelltransplantation (aSZT) bei hämatologischen Erkrankungen mittels helikaler Tomotherapie anhand einer retrospektiven Kohorte
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S105
    DOI (Open Access)
  • Bergmann, L.; Grünwald, Viktor; Maute, L.; Grimm, M. O.; Weikert, S.; Schleicher, J.; Klotz, T.; Greiner, J.; Westermann, J.; Hartmann, A.; Moritz, B.; Gauler, Thomas
    A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma : A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN)
    European Cancer Congress 2015 (ECC 2015), September 25-29, 2015, Vienna, Austria,
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 51, 2015, Nr. Suppl.3, S. S517
    DOI
  • Nell, I.; Gauler, Thomas; Nickel, A. C.; Alotaibi, S.; Thomale, Jürgen; Schuler, Martin; Hoffmann, Andreas-Claudius
    Pre-therapeutic ex-vivo repair kinetics of cisplatin-DNA-adducts in circulating tumor cells (CTC) as platinum resistance test
    11th Annual British Thoracic Oncology Group Conference, 23-25 January 2013, Dublin, Ireland,
    In: Lung Cancer. Amsterdam: Elsevier, Jg. 79, 2013, Nr. Suppl. 1, S. S2
    DOI
  • Gauler, Thomas; Theegarten, Dirk; Parr, A.; Schuhr, I.; Schmid, Kurt Werner; Eberhardt, Wilfried; Schuler, Martin; Hoffmann, Andreas-Claudius
    Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer
    14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S1114
  • Breitenbücher, Frank; Hoffarth, S.; Gauler, Thomas; Stergar, S. L.; Kasper, Stefan; Köhler, Jens; Worm, K.; Marten, A.; Schmid, Kurt Werner; Schuler, Martin
    Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
    14th World Conference on Lung Cancer, July 3 – 7, 2011, Amsterdam, The Netherlands,
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S956 – S957
    DOI